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ABSTRACT 
THE REGULATION OF RNA POLYMERASE I-MEDIATED TRANSCRIPTION IN 
FOREBRAIN NEURONS 
Scott Carl Smith 
November 29,2011 
Ribosomal biogenesis failure may contribute to neurodegenerative diseases, while 
its excessive activation has been shown to drive tumor growth. As ribosomal production 
is initiated and regulated by the Poll-mediated transcription of rRNA genes in the 
nucleolus, the latter process had the attention of most researchers interested in the 
dysregulation of ribosomal biogenesis in disease. When this work began, regulation of 
Poll-mediated transcription in neurons had been poorly characterized. The goal of this 
research has been to better define factors and signaling pathways that regulate neuronal 
Poll activity. The first hypothesis tested was that DNA damage induced by a DNA 
topoisomerase poison, etoposide, blocks neuronal Poll. Intracarotid delivery of 
etoposide to adult rats resulted in Poll inhibition in the neocortex; however no apoptosis 
was found. In neonate rats that received intracerebroventricular injections of etoposide 
we observed inhibition of Poll in neurons in the neocortex and hippocampus. Neuronal 
apoptosis was observed in these brain structures following etoposide treatment. 
Therefore, these results confirm that neuronal Poll is sensitive to etoposide-induced 
DNA damage and that such a sensitivity is present in both young and mature neurons of 
whole rats. These results also demonstrate that Poll inhibition is distinct from the 
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developmentally-restricted apoptotic response to etoposide. While working on these 
studies, we made the surprising finding that doses of etoposide induced Poll-mediated 
transcription in cultured cOJ1icai neurons and whole rat neonate brains. Thus, low doses 
of etoposide that were 3 orders of magnitude lower than those inducing Poll block 
apoptosis and were sufficient to activate Poll and the DNA double strand break response, 
including autophosphorylation of the DNA damage signaling kinase Ataxia-telangiectasia 
Mutated (ATM). Therefore, it was hypothesized that ATM activated neuronal Poll. 
Indeed, pharmacological inhibition of ATM with KU55933 blocked Poll activation in 
response to low concentrations of etoposide or to another topoisomerase-II inhibitor, 
ICRF-193. Basal levels of nucleolar transcription were also suppressed. Moreover, Poll-
driven transcription was reduced in the cerebellum of 5-week old ATM-null mice. 
Additionally, pharmacological inhibition of ATM reduced neuronal Poll activation in 
response to the neurotrophin, BDNF, or to increased synaptic activity. Consistent with 
the notion that BDNF-mediated neurite outgrowth requires Poll, KU55933 appeared to 
reduce BDNF-mediated neurite outgrowth. Similar effects on ribosomal biogenesis and 
neuronal growth were observed with a pharmacological inhibitor of the ATM-related 
kinase mTOR. Finally, ATM inhibition reduced Poll activation in serum-stimulated 
human cell lines. These findings identified A TM as a novel regulator of Poll. They 
further confirmed that in neurons, as in non-neuronal cells, mTOR also regulates Poll. 
My results suggest that at least some consequences of ATM deficiency in humans, 
including neurodegeneration or impaired proliferation, result from insufficient ribosomal 
biogenesis. 
VB 
Taken together, these studies filled important gaps in the knowledge of Poll 
regulation in neurons by demonstrating nucleolar transcription sensitivity to DNA 
damage in whole animal brains and by defining signaling pathways contributing to its 
activation by neurotrophic stimulation. My findings suggest that DNA damage or loss of 
TM may contribute to neurodegeneration by decreasing ribosomal biogenesis. 
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First described in neurons in 1839 by a pupil of Jan Evangelista Purkinje, Gabriel 
Valentin (Harris, 2000), the primary function of the nucleolus was only definitively 
agreed upon in 1965 (Pederson and Tsai, 2009). Within the nucleus, Valentin described a 
"sharply rounded object which thus constitutes a kind of nucleus within a nucleus." 
Indeed, the definition of the word, "nucleolus" is nucleus within a nucleus. Nucleolar 
function, identified primarily in transfonned cells, was the place of ribosomal biogenesis 
(Pederson and Tsai, 2009). Though key findings in the mid 1960's led many researchers 
to agree upon nucleolar function, it took a meeting in Uraguay by groups of scientists 
who had watched the development of nucleolar function to officially claim ribosomal 
biogenesis to the location of the nucleolus (Pederson and Tsai, 2009). In recent years with 
the development of advanced proteomics tools it was identified that only approximately 
30% of the more than 4500 proteins residing in the nucleolus are directly associated with 
ribosomal biogenesis. This has been interpreted to mean that though ribosomal 
biogenesis is a function of the nucleolus, it is not the only function. The plurifunctional 
nucleolus is regularly revealing new and exciting functions to the scientists who study it 
nearly 200 years after its description in animal cells was first published. 
Despite being the first described animal cell with a nucleolus, the nucleolus of the 
postmitotic neuron has gained attention only recently. The cellular function of neuronal 
nucleoli, the regulation of Poll transcription and the responsiveness to stress are all 
present in neurons as well as cycling cells; yet the fates of neurons are different from 
cycling cells. Only a small percentage of the total neuronal population of the brain 
regenerate, thus the longevity of neurons is of the utmost importance in healthy 
development and aging. Further, in neurons actively translating ribosomes are present in 
the soma, axons and dendrites of neurons. The functions of proteins being synthesized 
locally include axon guidance (Campbell and Holt, 2001), synapse formation (Schacher 
and Wu, 2002), neuronal survival (Howe and Mobley, 2005; Cox et aI., 2008), and 
synaptic plasticity (Ostroff et aI., 2002). Indeed, bidirectional transport of locally 
translated proteins is a means of signaling the great distance between the soma and 
synapse (Howe and Mobley, 2005; Cox et aI., 2008; Lin and Holt, 2008). In addition, 
morphogenesis ofneurites requires transcription leading to ribosomal biogenesis (Gomes 
et aI., 2011). Therefore the ongoing synthesis of ribosomes, the half-life of which is 7-15 
days (Stoykova et aI., 1983), is of utmost importance in neurons. The generation of new 
ribosomes may be important in maintaining neuronal function as the accumulation of 
oxidative damage has been identified in RNA of ribosomes of Alzheimer's disease 
patients (Honda et aI., 2005; Ding et aI., 2006). Most steps of ribosome synthesis occur 
in the nucleolus, a transcription-dependent nuclear structure. 
Nucleolar transcription of rRNA genes initiates ribosomal biogenesis and is 
tightly regulated to adjust the rate of ribosomal production to cellular needs. Pathways 
that signal cellular growth, such as mammalian target of rapamycin (mTOR), mitogen-
activated protein kinases (MAPK), extracellular signal-related kinase (ERK) and p90 
ribosomal S6 kinase (RSK), and cyclin-dependent kinases (CDKs) directly regulate the 
nucleolus (Grummt, 2003; Rubbi and Milner, 2003; Mayer et aI., 2005; Mayer and 
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Grummt, 2005; Boulon et aI., 2010; Drygin et aI., 2010; Hetman et aI., 2010). Nucleolar 
transcription is also affected by cellular stress. Nucleolar transcription is inhibited by 
DNA damage, reactive oxygen species or nutrient starvation (Rubbi and Milner, 2003; 
Mayer et aI., 2005; Mayer and Grummt, 2005; Kruhlak et aI., 2007; Kalita et aI., 2008). 
The nucleolar sensitivity to stress provides a convenient stress signaling mechanism. 
Stress-induced inhibition of ribosomal biogenesis preserves cellular energy (Grummt and 
Voit, 2010) and disrupts nucleolar integrity thereby allowing the passive diffusion of 
nucleolar-residing proteins that can mediate various stress responses throughout a cell, 
such as stabilization ofp53 (Rubbi and Milner, 2003; Andersen et aI., 2005; Mayer and 
Grummt, 2005). However, long-term reduction of ribosomal biogenesis may have 
permanent negative consequences on the cell. The pathology of ribosomopathies, whose 
origins are in decreased ribosomal biogenesis, provides evidence for this notion (Lipton 
and Ellis, 2009; Burwick et aI., 2011). In neurons, nucleolar transcription is necessary 
for neuronal development and maintenance (Parlato et aI., 2008). 
The present studies began as an attempt to identify DNA damaging agents that 
affected Poll transcriptional activity in neurons. With such tools, we planned to test 
whether DNA damage-induced nucleolar disruption occurs in both developing and 
mature brain. While conducting these studies we made a surprising discovery that a 
DNA damage signaling protein kinase, Ataxia-telangiectasia mutated (ATM) stimulates 
nucleolar transcription. Therefore, we discovered a novel regulator of nucleolar 
transcription that functions independently of canonical Poll-mediated regulatory 
signaling pathways. 
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The nucleolus and transcription of ribosomal RNA genes 
The nucleus is an organelle that encompasses non-membrane-bound structures, 
such as Cajal bodies, PML bodies, and others, all of which represent functional 
compartmentalization (Emmott and Hiscox, 2009). Biogenesis of the nucleolus is 
transcription dependent (Rubbi and Milner, 2003). The nucleolus contains a vast 
proteome as well as nucleic acids with a particular enrichment in RNA (Boisvert et aI., 
2007). Though once believed to be only a constitutive ribosome producer, the nucleolus 
is now known to be a highly dynamic compartment. It is responsive to growth stimuli 
(Grummt, 2003) and stress signals (Mayer et aI., 2005), and is involved in such diverse 
functions as DNA repair (Boisvert et aI., 2007), stress sensing (Mayer and Grummt, 
2005), RNA splicing and processing (Tschochner and Hurt, 2003; Andersen et aI., 2005; 
Wahl et aI., 2009). 
RNA Polymerase-l (Poll) is the nucleolar RNA polymerase which is the only 
mediator of nucleolar transcription of the repeated nucleolar genes encoding 18S, 28S 
and 5.8S rRNAs (ribosomal DNA, rDNA). Each of several hundred nucleolar rDNA 
units can be transcribed into a 45S precursor-rRNA (pre-rRNA), which is rapidly 
processed to the 18S, 28S, and 5.8S transcripts (Fig.!). Human rRNA genes are 
organized in tandem repeats at nucleolar organizer regions (NORs) on the p12 band of 
the acrocentric chromosomes (13, 14, 15,21, and 22) (Grummt, 2003; Mais et aI., 2005; 
Drygin et aI., 2010). Ribosomal biogenesis begins with the transcription ofrDNA by 
Poll at NORs in the fibrillar center (FC) of the nucleolus. The processing of pre-rRNA is 
accomplished by small nucleolar ribonucleoproteins (snoRNPs) in the dense fibrillar 
component (DFC) of the nucleolus, just exterior to the FC (Boisvert et aI., 2007). The 
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final maturation of ribosomal transcripts and assembly with ribosomal proteins occurs in 
the granular component (GC) of the nucleolus, the region furthest from the Fe and 
closest to the nucleoplasm. The 5S rRNA transcript, transcribed by RNA Polymerase-III 
outside the nucleolus, assembles with the 28S and 5.8S rRNA transcripts and ribosomal 
proteins to form the 60S subunit (Boisvert et aI., 2007; Strunk et aI., 2011). The mature 
18S rRNA transcript assembles with ribosomal proteins to form the 40S subunit. The 
40S and 60S subunits are individually exported to the nucleoplasm and subsequently 
assembled together to form the mature ribosome (Boisvert et aI., 2007). 
Ribosomal biogenesis is extremely costly to the cell (Warner, 1999). In 
Scerevisiae approximately 2000 ribosomes are generated per minute. The toll this takes 
on the cell accounts for 60% of the total cellular transcriptional output, and is the sum of 
no less than 50% of RNA Polymerase II-mediated transcription. PolII is required to 
transcribe 137 mRNAs, accounting for 78 ribosomal proteins that are directly involved in 
ribosomal biogenesis. Indeed, enzymes such as kinases that regulate ribosomal 
biogenesis are not even accounted for in these calculations (Warner, 1999). 
Synthesis ofrRNA is highly regulated as would be expected for such an energy-
requiring process. Ribosomal biogenesis requires the cooperation and activation of 
multiple co-factors (Fig.2). Pre-initiation complex assembly requires the recruitment of 
upstream binding factor (UBF) and transcription initiation factor - IB (rodent)/promoter 
selectivity factor (humans) (TIF-IB/SLl) (Drygin et aI., 2010). DNA binding by the UBF 
high mobility group (HMG) box allows the bending of approximately 140 base pairs (bp) 
which creates an enhancosome structure to promote transcription (Bazett-Jones et aI., 
1994). The UBF-mediated enhancosome structure stabilizes TF-IB/SLl promoter binding 
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and recruits Poll (Drygin et aI., 2010). UBF also engages in the promotion of 
transcriptional elongation. The assembly of a productive transcription initiation complex 
depends on Poll recruitment. TIF-IB, made up of the TATA binding protein and TATA 
binding protein-associated factors, T AF 1 proteins, recruits Poll. The interaction between 
TAFls ofTIF-IB/SLl and TIF-IA creates a bridge between TIF-IB/SLl and RPA43, a 
subunit of Poll (Grummt, 2003; Drygin et aI., 2010). 
Epigenetic modification of rDNA can also enhance or repress nucleolar 
transcription. Though not as rapid as the transcriptional regulation of active rDNA by 
signaling pathways, epigenetic modification can regulate the transcriptional output of the 
nucleolus by recruiting silenced rDNA to an active state or vice versa (Grummt and 
Ladumer, 2008). Importantly, epigenetic modification of rDNA can be mediated by cell-
extrinsic factors that are critical to cell growth, such as glucose levels (Murayama et aI., 
2008). Promoters of silenced rRNA genes are hypermethylated at CpG residues. The 
nucleolar remodeling complex (NoRC) silences rDNA by recruiting DNA 




Ribosomal DNA repeats 
Pol1 
••••• m ••••••• Ribosomal DNA gene 
45S rRNA precursor 
1 rapid rRNA processing 
--_/ 
5.8S 
Figure 1: The nucleolus is a transcription-mediated organelle. 
Ribosomal DNA (rDNA) is organized in tandem repeats in nucleolus. Transcription ofrDNA is 
conducted by RNA Polymerase I , which produces the 45S precursor rRNA (pre-rRNA or 45S 
rRNA). Rapid processing of rRNA results in the mature I8S, 5.8S and 28S transcripts. 
7 
Figure 2 
Figure 2. A diagram of the transcription initiation unit as described in the text. 
A productive transcription initiation complex requires the UBF - TIF -1 B/SL 1 stabilization on the 
promoter, leading to the recruitment of Poll . Interaction between TIF -1 B and Poll is mediated 
by TIF-lA. 
Role of the nucleolus in cell growth 
During neuronal development, establishing connections of individual neurons to 
one another is dependent upon extracellular signals, such as growth factors, electrical 
activity and neurotransmitters. Local protein synthesis is often required to respond to 
many such signals (Alvarez et aI., 2000; Ethell and Pasquale, 2005; Howe and Mobley, 
2005; Matus, 2005; Lin and Holt, 2008; Gumy et aI. , 2010; Jan and Jan, 2010; Mikl et aI. , 
2010; Neal et aI., 2010; Gutierrez and Davies, 2011). The response to these signals results 
in the activation of intracellular signaling cascades that stimulate neurite outgrowth and 
synaptogenesis (Miller and Kaplan, 2003). Thus, as an initiator of ribosomal biogenesis, 
nucleolar transcription is critical for cellular growth. An important mediator for such 
regulation is TIF-l A with a variety of signaling pathways that converge on it (Grummt, 
2003). mTOR regulation of Poll-mediated transcription is accomplished through 
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phosphorylation ofTIF-IA. mTOR promotes the activation of Poll-mediated 
transcription by phosphorylating S44 and inhibits Poll transcription by phosphorylating 
S199 (Mayer et aI., 2004). ERK1I2 regulation ofTIF-IA potentiation occurs with the 
cooperation ofp90 ribosomal S6 kinase (RSK). Mitogen stimulation occurs through 
receptor tyrosine kinase (RTK) and the signaling cascade follows through RAS, RAF, 
MEK and finally to ERK1I2. ERK1I2 then activates RSK, which phosphorylates TIF-IA 
at S649. That is followed by ERK1I2-mediated phosphorylation ofTIF-IA at S633. 
Both phosphorylations are required for ERK1I2-mediated TIF-IA activity. 
Brain-derived neurotrophic factor (BDNF) is a major neurite outgrowth-
promoting neurotrophin for forebrain neurons. BDNF binds TrkB receptors that signal to 
TIF-IA via RAS and ERK1I2 pathways to regulate neurite outgrowth and induce primary 
dendrite formation through the activation of MAP kinase and PI3K signaling pathways 
(Dijkhuizen and Ghosh, 2005). BDNF-mediated outgrowth of neurites has recently been 
shown to be TIF-IA-dependent via ERK1I2 signaling (Gomes et aI., 2011). In that study, 
the constitutive activation ofMKKI induced neurite outgrowth similar to BDNF-induced 
outgrowth in a TIF-IA-dependent manner. Similarly, constitutively active TIF-IA also 
induced neurite outgrowth. Indeed, such findings suggest that Poll is a critical pro-
growth target ofERK1I2 (Gomes et aI., 2011). 
mTOR signaling that is activated by insulin and neurotrophins through RAS-
dependent activation of Phosphat idyl inositol 3-kinase (PI3K) also contributes to neurite 
outgrowth and branching. While its role in promoting neurite outgrowth has been 
attributed to its effect on translation (Jaworski et aI., 2005; Swiech et aI., 2008), mTOR is 
also a major regulator of Poll and ribosomal biogenesis by targeting TIFIA (Grummt, 
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2003; Drygin et aI., 2010). However, whether that Poll-driven activity ofmTOR is 
essential for neurite outgrowth remains to be determined. 
In addition to TIFIA, other initiation complex co-factors are regulated by growth 
promoting signaling pathways. UBF phosphorylation by ERKl/2 in response to 
mitogenic signals at Tll7 and T201 robustly modifies the DNA architecture of the 
enhancosome to promote Poll transcription through it (Stefanovsky et aI., 2001; 
Stefanovsky et aI., 2006). mTOR phosphorylates UBF at its C-terminus thereby 
promoting the interaction between UBF and TIF-IB/SLl in response to growth signals 
and nutrients (Hannan et aI., 2003). In proliferating cells, cyclins and their kinases 
activate UBF during cell cycle progression. Cyclin E/Cdk2 and Cyclin AlCdkl 
phosphorylate UBF during interphase on S484 by Cyclin D/Cdk4 and Cyclin E/Cdk2 and 
on S388 (Drygin et aI., 2010 86). 
Nucleolar roles beyond ribosomal biogenesis 
A vast proteome in the nucleolus has been identified suggesting that the 
functional significance of the nucleolus goes beyond ribosomal biogenesis (Andersen et 
aI., 2005). Annotations of nucleolar proteins have implicated the nucleolus in processes 
such as apoptosis, cell stress signaling, DNA repair, signal recognition particle 
biosynthesis, telomere function, aging, and synaptic activity, among others (Pederson, 
1998; Mayer and Grummt, 2005; Jordan et aI., 2007). Proteins directly related to 
ribosomal biogenesis account for only 30% of the nucleolar proteome (Andersen et aI., 
2005; Boulon et aI., 2010). Proteins can freely diffuse in and out of the nucleolus since 
there is no membrane boundary, therefore the retention of many proteins to the nucleolus 
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depends on the affinity to bind relatively immobile components of that structure 
(Pederson and Tsai, 2009). Conversely, upon inhibition of Poll, many nucleolar proteins 
diffuse throughout the nucleoplasm and/or the cytosol. One such protein, 
NucleophosminIB23, is a multi-functional histone chaperone protein (den Besten et aI., 
2005; Maggi et aI., 2008; Nalabothula et aI., 2010; Colombo et aI., 2011). It is required 
for the correct assembly and disassembly of nucleosomes (Maggi et aI., 2008; Colombo 
et aI., 2011), participates in shuttling pre-ribosome particles from their point of synthesis 
to the cytoplasm (den Besten et aI., 2005), and after its nucleolar release following Poll 
inhibition, is involved in cell cycle arrest (Nalabothula et aI., 2010) and p19ARF 
stabilization (Colombo et aI., 2011). 
The nucleolus as a stress sensor 
rDNA transcription is highly sensitive to stress including exogenous DNA 
damage, oxidants, hypoxia, heat shock (Rubbi and Milner, 2003), or nutrient starvation 
(Mayer et aI., 2004). The mechanisms associated with the suppression of rDNA 
transcription have been investigated only recently (Boulon et aI., 20 I 0). Following 
nutrient starvation, increasing AMP/ATP ratio activates a protein kinase AMPK, which 
carries out inhibitory phosphorylation ofTIFIA at S635 (Grummt, 2003; Hoppe et aI., 
2009). In response to exogenous oxidative stress, nucleolar transcription suppression is 
dependent upon c-jun N-terminal protein kinase 2 (JNK2) (Mayer et aI., 2005) that also 
targets TIF 1 A. Similarly, Poll-mediated transcriptional inhibition following irradiation 
or etoposide has been shown to be ATM-dependent (Kruhlak et aI., 2007). 
As the nucleolus is a transcription-dependent structure, inhibition of Poll disrupts 
nucleolar integrity (Olson, 2004; Boulon et aI., 2010). The disrupted nucleolar integrity 
11 
has been characterized ultrastructurally as the separation of the FC and Gc. In addition, 
many nucleolar proteins are released from the nucleolus critically contributing to the 
stress responses such as p53-mediated apoptosis (Boulon et ai., 2010). Under basal 
conditions p53 is continuously ubiquitinated by the E3 ligase, MDM2, and thereafter 
degraded in the cytoplasm. Upon nucleolar disruption, ARF is released to the 
nucleoplasm where it binds up MDM2 thereby preventing its association with p53. This 
allows p53 to accumulate in the nucleus and be a responsive genotoxic effector (Rubbi 
and Milner, 2003). Nucleophosmin also binds ARF thereby preventing its association 
with E3 ligases (Colombo et ai., 2011). In addition, ribosomal proteins L5, LIl, L23 and 
S7 have been shown to directly associate with MDM2 to prevent p53 degradation. Such 
interactions are promoted by nucleolar disruption (Boulonet ai., 2010). Alternatively, 
increased translation ofLl1 can promote p53 accumulation even if nucleolar structure is 
undisturbed. LIl mRNA contains a 5' -terminal oligopyrimidine sequence that allows 
translation of a subset of mRNAs under global translation inhibition. Indeed, 40S 
ribosomal subunit biogenesis inhibition drove LII mRNA translation leading to p53 
acetylation in the absence of nucleolar disruption (Fumagalli et ai., 2009; Boulon et ai., 
2010). Post-translational modifications ofp53 can promote its accumulation following 
stress. For instance, acetylation ofp53 and MDM2 by p300/CBP prevents their binding 
following nucleolar stress. Under non-stress conditions, however, MDM2 suppresses 
p53 acetylation (Boulon et ai., 2010). 
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Neurodegenerative disease and impaired nucleolar transcription 
Chronically impaired nucleolar transcription has negative consequences on non-
proliferating cells (Kalita et aI., 2008; Parlato et aI., 2008; Hetman et aI., 2010; Rieker et 
aI., 2011). Impaired nucleolar transcription by the genotoxin, camptothecin, or the small 
hairpin RNA knockdown of the nucleolar transcription co-factor, Tif-la, causes neuronal 
nucleolar disruption and apoptotic cell death in cultured cortical neurons from newborn 
rats (Kalita et aI., 2008). Similarly, ablation of Tif-la in the developing CNS causes 
massive apoptosis of neuronal precursors that prevents brain development (Parlato et aI., 
2008). In both dissociated neurons and in the whole animal, the accumulation ofp53 in 
neurons is a trigger for relatively rapid apoptotic death upon Poll inhibition. Conversely, 
if Tif-la is eliminated from the mature nervous system, slow-progressing 
neurodegeneration occurs. The first evidence becomes noticeable one month following 
the induced knock out of the Tif-l a gene and continues for at least 30 weeks, at which 
time 80% of neurons are lost (Parlato et aI., 2008). This is consistent with the long half-
life of neuronal ribosomes (Stoykova et aI., 1983). Impaired nucleolar transcription 
likely hinders ribosome production and renewal leading to ribosomal failure, insufficient 
protein synthesis and subsequent neuronal atrophy (Hetman & Pietrzak, 2011, in press). 
In addition, the disruption of nucleolar integrity may allow the diffusion of nucleolar 
proteins into the nucleoplasm that have chronic negative effects on the cell, such as the 
accumulation ofp53 (Emmott and Hiscox, 2009) (Fig. 3). 
Evidence of accumulated oxidative stress is prevalent in many neurodegenerative 
diseases (Zhang et aI., 1999; Sayre et aI., 2001; Ding et aI., 2005; Honda et aI., 2005; 
Barber et aI., 2006; Ding et aI., 2006; Markesbery and Lovell, 2006; Brooks, 2007; Fishel 
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et ai., 2007; Lovell and Markesbery, 2007b; Martin, 2008b; Nunomura et aI., 2009; 
Kirshner et ai., 2011). Indeed, in PD and AD, there is evidence that RNA oxidation 
occurs in the cytoplasm and affects ribosomes (Zhang et aI., 1999; Ding et aI., 2005; 
Honda et aI., 2005; Ding et aI., 2006; Nunomura et ai., 2009): In AD, this has caused 
ribosomes to have reduced protein translation efficiency thereby preventing sufficient 
cellular maintenance and contributing to the vicious cycle of AD pathology (Ding et aI., 
2005). Conversely, increased susceptibility to oxidative stress may stem from impaired 
nucleolar transcription (Rieker et aI., 2011). 
The ablation of Tif-la specifically in developing dopaminergic neurons also 
causes a substantial reduction in tyrosine hydroxylase-positive neurons from the 
substantia nigra and striatum only 15 days after birth. At postnatal day 30 there were 
significant locomotor deficits associated with ablation of Tif-I a in dopaminergic neurons 
(Rieker et aI., 2011). As may be expected, ablation of Tif-I a in mature dopaminergic 
neurons using a tamoxifen-inducible Cre-recombinase caused a reduction in 
dopaminergic neurons as early as seven weeks following initial tamoxifen injections, 
reduced dopamine content of dopaminergic neurons, and within 12 weeks produced 
locomotor deficits (Rieker et aI., 2011). These results point to the necessity of Poll-
mediated transcription for dopaminergic neuronal maintenance, suggesting a possible 
relationship between nucleolar insufficiency and PD. In fact, disrupted nucleoli in 
dopaminergic nigral neurons have been documented in postmortem brain samples from 
PD patients (Rieker et aI., 2011). 
Excessive epigenetic silencing ofrDNA has also been linked to the hippocampal 
atrophy in severe depression of developmental origin and AD. Hypermethylation of 
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rDNA promoter CpGs was observed in the postmortem hippocampus of suicide victims 
with depression and a history of childhood abuse (McGowan et aI. , 2008). Similar 
hypermethylation has been documented in the cerebral cortex of AD patients and in the 
elderly with mild cognitive impairment, which often represents early stage AD (Pietrzak 
et aI., 2011a). These findings may suggest active rDNA silencing mediated by cellular 




Nucleolar proteins activating the 
stress response 
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~ Damaged, inactive ribosome 
Figure 3: Potential consequences of nucleolar insufficiency. 
Long-lasting nucleolar transcriptional impairment may prevent the sufficient renewal of 
ribosomes that are readily oxidized loosing their translational activity (Hetman & 
Pietrzak, submitted). That may lead to ribosomal failure and reduction in protein 
synthesis (Honda et aI. , 2005; Ding et aI. , 2006). In addition, the diffusion of nucleolus-
residing stress response proteins into the nucleoplasm/cytoplasm may trigger chronic 
activation of stress signaling including accumulation ofp53 (Rubbi and Milner, 2003 ; 
Emmott and Hiscox, 2009; Boulon et aI. , 2010). 
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DNA damage and repair in the nervous system 
Age-related onset ofneurodegeneration is likely in part a function of the neuronal 
accumulation ofunrepaired DNA damage (Rutten et aI., 2003; Barber et aI., 2006; 
Culmsee and Landshamer, 2006; Dolle et aI., 2006; Droge and Schipper, 2007; Loerch et 
aI., 2008; Martin, 2008a; McKinnon, 2009). Increased oxidative damage to cell 
membranes, proteins and nucleic acids, including DNA, has been demonstrated in the 
most prevalent of the adult-onset neurodegenerative diseases such as Alzheimer's disease 
(AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) (Ferrante et aI., 
1997; Gabbita et aI., 1998; Zhang et aI., 1999; Dizdaroglu et aI., 2002; Lovell and 
Markesbery, 2007a, b). 
Due to its high oxygen consumption rate (approximately 20% of consumed 
oxygen), the brain has an increased susceptibility to oxidative damage compared with 
other organs. This damage is generated by reactive oxygen species (ROS) derived 
primarily from the process of oxidative phosphorylation (Lovell and Markesbery, 2007b). 
Oxidative reactivity to DNA results in the creation of numerous oxidized base adducts, 
the most prominent of which is 8-hydroxyguanine (8-0HG). ROS can also cause strand 
breaks and DNA cross links with DNA and proteins (Ferrante et aI., 1997; Dizdaroglu et 
aI., 2002). Studies of post-mortem AD patients have identified increased 8-0HG levels 
in mitochondrial DNA (mtDNA) in the parietal lobe (Mecocci et aI., 1993), and in 
nuclear DNA (nDNA) from the temporal and parietal lobes (Gabbita et aI., 1998). 
Evidence that such DNA damage triggered DNA damage response has been 
shown in human diseases and/or animal models of the disease. The accumulation ofp53 
and presence of activated caspase 3 has been demonstrated in human post-mortem brains 
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of AD patients, as well as in the brains of transgenic mice overexpressing Ap. Similarly, 
oxidative insult resulted in p53-dependent apoptosis in the substantia nigra of mice 
rendered parkinsonian by I-methyl-4-phenyl-l,2,3,6-tetrahydropyridine- (MPTP). 
Though many studies have demonstrated that cell loss is prominent in the AD, PD, and 
ALS post-mortem human central nervous system (CNS) (Honig and Rosenberg, 2000), 
the mechanisms of degenerative changes at the early-stages of these conditions are 
unknown (Droge and Schipper, 2007). Indeed, apoptosis following DNA damage has 
been demonstrated in developing neurons and in whole animals, but is attenuated in 
mature neurons (Lesuisse and Martin, 2002; Martin, 2008a; McKinnon, 2009). 
Neurons can accumulate various forms of DNA damage. The repair of oxidative 
lesions can lead to the release of free bases, or apurinic/apyrimidinic sites (AP). The 
presence of a lost purine or pyrimidine and the deoxyribose with a cut in the 
phosphodiester backbone of one strand is a single strand break (SSB), which may also be 
formed by X-rays, and topoisomerase I inhibiting chemotherapy agents, such as 
camptothecin (CPT) (Morris and Geller, 1996; McMurray, 2005). Chemical agents, such 
as the commonly used chemotherapy agents, etoposide and cisplatin, and gamma-
irradiation may induce chemical cross-linking of two complementary DNA strands, 
termed interstrand cross-links (ICLs) and cuts in both strands, termed double strand 
breaks (DSBs). 
Genotoxic lesion repair in post-mitotic neurons employs similar machinery as in 
other cells. The frequency of genotoxic lesions mediates the activity prominence of the 
repair pathway. Base excision repair (BER) is the primary repair pathway (Fishel et aI., 
2007), followed by, nucleotide excision repair (NER) and non-homologous end joining 
17 
(NHEJ). Homologous recombination (HR) is believed to be relatively inactive in 
neurons (McMurray, 2005; Fishel et aI., 2007; Lee and McKinnon, 2007). DSB are 
repaired by NHEJ and HR pathways (McKinnon, 2009). HR is functional only in 
proliferating cells, whereas NHEJ is active in proliferating and differentiating cells, such 
as in the mature nervous system. DSB detection is conducted by ataxia telangiectasia, 
mutated (ATM), ataxia telangiectasia and RAD3-related (ATR), or DNA-dependent 
protein kinase (DNA-PK) (Hoeijmakers, 2001; McKinnon, 2009). NHEJ is not error-free 
and proceeds with the recruitment of the subunits ofDNA-PK, KU70 and KU86 to the 
open ends of DNA, which recruits the catalytic subunit of DNA-dependent protein kinase 
(DNA-PKcs). Without a template to synthesize from, the two broken ends are linked 
together by ligase 4 (LIG4), which may result in the gain or loss of nucleotides 
(Hoeijmakers, 2001; McKinnon, 2009). 
The signaling of strand breaks involves DNA damage signaling kinases, including 
poly(ADP-ribose) polymerase I (PARP), ATM, ATR and DNA-PK (Hoeijmakers, 2001; 
Caldecott, 2008; McKinnon, 2009). ATM is activated by autophosphorylation via 
interaction with Nijmegen breakage syndrome 1 (NBSl) and the remaining members of 
the MRN complex (component proteins, MREll, RAD50) (Goodarzi et aI., 2004; Lavin, 
2004; Iijima et aI., 2008; Morio and Kim, 2008). ATM substrates for a cell salvaging 
pathway include those responsible for arresting cell cycle and commencing repair 
(including CHK2 and DNA-PK), whereas substrates of the suicide pathway include p53, 
caspase 3 and PUMA (Hoeijmakers, 2001; Lee and McKinnon, 2007; Morio and Kim, 
2008; McKinnon, 2009). The inhibition of DNA topoisomerases has been shown to 
activate the DNA damage signaling kinases. Topoisomerase inhibitors, etoposide 
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(topoisomerase II) (Kruman et aI., 2004; Besirli and Johnson, 2006) and camptothecin 
(topoisomerase I) (Sordet et aI., 2009), activate ATM in post-mitotic neurons. The latter 
study demonstrated this finding in a manner independent ofDNA-PK. 
Topoisomerases and their chemical inhibitors 
The topoisomerases (I and II) catalyze DNA topology rearrangement to maintain its 
energetically stable forms from the relaxed or super-coiled DNA forms (Sharma and 
Mondragon, 1995; Bates and Maxwell, 1997). Topoisomerase I regulates DNA topology 
by cleaving one strand of DNA and creating a covalent 3' -phosphotyrosine bond at its 
catalytic center (Pommier, 2009). Mammals have two topoisomerase II isoforms, a and 
p. Topoisomerase lIa is present in proliferating tissues, while IIp is abundant in 
terminally differentiated cells (Nur et aI., 2007). It is particularly important in neural 
development, demonstrated by the failure of to poi some rase liP knock out mice to 
establish neuromuscular junctions (Yang et aI., 2000) and inhibited neuronal 
differentiation following its pharmacological inhibition (Tsutsui et aI., 2001) (Nur et aI., 
2007). Topoisomerase II regulates DNA topology by creating a DSB and then passing a 
double helix through it (Baldwin and Osheroff, 2005). Topoisomerase II forms a 
covalent 5'-phosphotyrosine bond on both strands of DNA (Pommier, 2009). The DSBs 
created by topoisomerase Il are always protein-bound and thus do not elicit DNA damage 
responses (Nitiss, 2009a). 
The poisoning of to poi some rases bound to DNA has been used in anti-cancer 
treatments for decades. Camptothecin and etoposide are both derived from plants, 
Camptotheca acuminate (Pommier, 2009) and Podophyllum peltatum (Baldwin and 
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Osheroff, 2005), respectively. The camptothecin derivative topotecan is currently 
approved for treatments of ovarian cancers and small-cell lung cancers, whereas another 
derivative, irinotecan, is approved for treatment of colorectal tumors, (Pommier, 2009). 
Being of planar aromatic structure, camptothecin stacks between the base pairs next to 
the 3' -pho sphotyro sine DNA-protein interface, thereby trapping the topoisomerase I 
cleavage complex. Once trapped on the DNA of a post-mitotic cell, a transcription 
blockage can result. Indeed, camptothecin is a potent inhibitor of nucleolar transcription 
in cancer cell lines (Pommier et aI., 2006). The reversible, trapped topoisomerase 
cleavage complex is removed by tyrosyl-DNA-phosphodiesterase I (TDPI) and BER 
(Pommier, 2006). 
Etoposide is also planar and aromatic, yet its precise mechanism of action remains 
unclear. However, it is known that etoposide acts after topoisomerase II has cleaved 
DNA, but prior to its relegation (Nitiss, 2009b). Studies have demonstrated that two 
molecules of etoposide are required to induce double strand breaks in DNA (Bromberg et 
aI., 2003). These findings suggest that, like camptothecin, etoposide inserts itself 
between the base pairs next to the 5' -phospho tyro sine DNA-protein interface and 
stabilizes the enzyme on the cleaved DNA. Yet the inhibition of topoisomerase II 
activity by etoposide has also been demonstrated to produce single strand breaks 
(Rogojina and Nitiss, 2008). There are numerous etoposide analogs, one significant to 
the work described herein is meso-2,3-bis(2,6-dioxopiperazin-4-yl)butane (ICRF-193), a 
topoisomerase II catalytic inhibitor whose activity blocks enzyme turnover by 
maintaining it in a closed confirmation. ICRF-193 will therefore have less genotoxic 
potential than etoposide. 
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Etoposide is one of the most widely used chemotherapy agents, approved by the 
FDA in 1983 prior to any knowledge that its target was topoisomerase II (Baldwin and 
Osheroff, 2005). Often in combination with cisplatin, etoposide has been used in the 
treatment of small-cell lung cancer (Sher et al., 2008), testicular cancer (Feldman et al., 
2008), among others, as well as in intra-arterial delivery to the brain for high grade 
astrocytomas (Madajewicz et al., 2000; Newton, 2005). It is also used for pediatric 
medullablastoma, primitive neuro-ectodermal tumors, and germ cell tumors. Its use has 
been extended as a single agent treatment for pediatric oncology involving 
neuroblastoma, leukemia, Ewing's sarcoma, soft tissue sarcoma, osteogenic sarcoma and 
Wilms' tumor (Lowis and Newell, 1996). Etoposide has gained clinical attention in the 
treatment of pediatric high-grade gliomas because of its effectiveness and reduced risk of 
endocrinological and neurocognitive deficits (Dufour et al., 2006). 
Ataxia-telangiectasia mutated (ATM) protein kinase 
A member of the phosphatidylinositol 3-kinase (PI3K)-like family of serine/threonine 
protein kinases (PIKKs), ATM is a 300kD Ser/Thr protein kinase that responds to 
genotoxic insult. Named for its causal role in the autosomal recessive disorder, Ataxia-
telengiectasia (A-T), A-T mutated protein kinase (ATM) was originally identified 
following reduced inhibition of DNA synthesis in response to increasing doses of 
ionizing radiation (Houldsworth and Lavin, 1980; Painter and Young, 1980; Lavin, 
2008). ATM mediates the signaling of DNA double stranded breaks (DSB) to numerous 
downstream targets, including BRCA1, p53, Chk2, CDK2, and H2AX in order to 
facilitate a range of cellular processes that include DNA repair and cell cycle control. 
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The activated downstream signaling of ATM has been observed to be required for the 
cellular response to genotoxic insult (irradiation and etoposide treatment) in the nucleolus 
(Kruhlak et aI., 2007), as ATM absence resulted in continued Poll-mediated 
transcriptional activity. 
To successfully transduce the message of genotoxic damage, ATM must itself be 
activated. This activation first involves the monomerization of A TM from its inactive 
dimer form, and subsequent activation by autophosphorylation and acetylation (Bakkenist 
and Kastan, 2003; Sun et aI., 2007; Sun et aI., 2009; Kozlov et aI., 2011). 
Autophosphory1ations at S 1981, S 1893 and S367 are well-characterized and mutations of 
these sites in A-T cells are unable to sufficiently correct radiation-induced cell-cycle 
defects (Bakkenist and Kastan, 2003; Koz10v et aI., 2006). Interestingly, bacterial 
artificial chromosome (BAC) constructs using serines mutated to alanines on these 
autophosphorylation sites were introduced into an Atm-I- background and ATM 
autophosphorylation and downstream signaling was normal (Pellegrini et aI., 2006; 
Daniel et aI., 2008). These findings prompted the identification of additional DNA 
damage-induced ATM autophosphorylation sites (Kozlov et aI., 2011). 
Recently the identification of A TM activity in its "inactive" dimerized state 
provided evidence of a novel DNA repair function. Hydrogen peroxide caused the 
activation of the dimerized form of ATM to phosphorylate a substrate, the N-terminus of 
a glutathione S-transferase (GST)-p53 in HEK293T cells in vitro (Guo et aI., 201Oa; Guo 
et aI., 2010b) in the absence ofDSBs. The authors later confirmed that the 
FRAP/ATMlTRRAP C-terminal domain (FATC) was responsible for the oxidative 
damage signaling of ATM. A mutation of cysteine residue 2991 allows DSB-induced 
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ATM signaling, but is unresponsive to H202. Although autophosphorylation at S198l 
was not increased, no other DNA damage-mediated autophosphorylation sites were 
evaluated (Guo et aI., 20 lOa; Guo et aI., 20l0b). The importance of these findings is 
three-fold: first, a subset of A-T patients, termed A-T variants, exhibit only moderate 
radiosensitivity and no immunodeficiency, yet still acquire the primary neurological 
component of A-T, ataxia. This mutation results from the entire lack of the last 10 amino 
acids on the C-terminus. The protein made from this mutation, R3047X, is fully 
activated by the MRN complex, but is not activated by oxidation in vitro (Guo et aI., 
201 Ob). Second, a novel A TM activation pathway has been established with an 
activating stimulus that was anticipated, based upon decreased lymphoma incidence and 
the reduced loss of hematopoietic stem cells in Atm
Olo 
mice treated with antioxidants (Ito 
et aI., 2004; Reliene and Schiestl, 2007; Reliene et aI., 2008). Lastly, the dimeric form of 
ATM accomplishes the signaling mediated by the oxidative stress stimulus (Guo et aI., 
2010a; Guo et aI., 201Ob). 
ATM: more than a DNA damage signaling molecule 
During the last decade publications have arisen sporadically, which implicate ATM in 
non-DNA damage response-related activities. These studies have been prompted by the 
varied phenotypic consequences of an insufficiency in ATM, as described by the 
autosomal recessive disorder, A-T. A-T patients suffer from high incidences of type 2 
diabetes mellitus, progeria, telangiectasias, and neurological phenotypes that include 
cerebellar ataxia and speech defects, as well as the expected increased cancer incidence 
and radiosensitivity (McKinnon, 2004; Lavin, 2008). Thus, it has been shown that ATM 
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is activated by insulin to stimulate translation via the direct phosphorylation of 4 E-BP I , 
which then triggers the phosphorylation-dependent release of 4E-BPI from eIF-4E (Yang 
and Kastan, 2000). These studies have been followed up to show that ATM mediates the 
activity of AKT to promote survival, without which apoptosis occurs in cycling cells 
(Halaby et aI., 2008; Li and Yang, 2010). 
The origin of the neurological phenotype associated with A-Tis yet unknown. 
Recent work has identified mild to severe cognitive impairments in A-T patients, 
consistent with A-T Like Disorders (ATLD). ATLD is rooted in the impaired function of 
MRE 11, Rad50, or NBS 1 genes, who respectively code for the proteins that make up the 
MRN complex. However, unlike ATLD, the A-T neurological component does not 
include microcephaly, but rather cerebellar atrophy and language impairment was 
restricted to oral motor impairments (Vinck et aI., 2011). As the most noticeable deficit 
is ataxia that usually begins in the second decade of life, it is logical that the identified 
speech deficits would be motor-based. The most common theories of the 
neurophenotype origin include the inability of neurons to signal damage (oxidative or 
DSB) to be repaired. 
Neuronal ATM is found in the nucleolus, the nucleoplasm and in the cytoplasm 
(Gorodetsky et aI., 2007). Recent work has indicated that the cytoplasmic form of ATM 
signals to synapsin-l, a vesicle component, to regulate neurotransmitter release (Li et aI., 
2009), the absence of which has profound effects on hippocampal long-term potentiation 
in mice. The implications of this work include the novel function of A TM, its residence-
specific function, and the likely contribution to the neurological component of A-T. 
While the nucleolar enrichment of ATM prompted speculations about its possible role in 
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maintaining the high rate of nucleolar transcription, perhaps by repairing transcription 
related DNA damage (Gorodetsky et aI., 2007), experiments testing such a notion have 
not yet been reported. 
Targets promoting sufficient neuronal nucleolar transcription 
Collectively, nucleolar transcription appears critical for neurons in regulating their 
growth. In addition, by ribosomal renewal and stress sensing including monitoring of 
genomic integrity, the nucleolus plays an essential role in neuronal maintenance. Finally, 
the nucleolus appears to be a target of neurodegeneration. However, regulation of 
nucleolar transcription in neurons remains poorly understood. In particular, when this 
work began it had not been known whether DNA damage could disrupt neuronal 
nucleolar transcription in the intact animal brain and whether such a disruption may occur 
in mature adult neurons. Additionally, no signaling pathway other than ERKl/2 had been 
implicated as a regulator of neuronal Poll. This study took advantage of the 
topoisomerase-II poison, etoposide, to test the hypothesis that nucleolar transcription is 
sensitive to DNA damage in whole animal brains and that such sensitivity is not age-
restricted. In addition, we followed accidental observations suggesting ATM's 
involvement in Poll regulation and tested the hypothesis that this kinase stimulates 
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Introduction 
Oxidative damage to neuronal DNA, including chemical modifications of DNA 
bases and single strand breaks (SSBs), is well-documented in several age-dependent 
neurodegenerative conditions including Alzheimer's- or Parkinson's diseases 
(Markesbery and Lovell, 2006; Martin, 2008a). In addition, the accumulation of 
oxidative DNA damage in neurons has been demonstrated during brain aging (Brasnjevic 
et aI., 2008; Yankner et aI., 2008). However, it is unclear whether such genomic injuries 
contribute to age-related neurodegeneration or represent an epiphenomenon of oxidative 
stress. Therefore, it is critical to test whether the neurodegeneration-associated forms of 
DNA damage result in neurotoxic consequences in the adult or aging brain. 
Studies of neurons from embryonic and/or neonatal rodents have identified 
apoptotic cell death as a major neuronal response to DNA damage. Neuronal apoptosis 
has been observed following challenges with DNA strand break inducers, such as 
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topoisomerase inhibitors or ionizing irradiation (Enokido et aI., 1996; Morris and Geller, 
1996; Herzog et aI., 1998; Martin et aI., 2009). However, that effect is limited to 
relatively immature neurons (Herzog et aI., 1998; Martin et aI., 2009). Therefore, a non-
apoptotic response to neuronal DNA damage may be more relevant for the pathogenesis 
of age-dependent neurodegenerative diseases. 
Genetic defects of several DNA repair pathways, including those for single- or 
double DNA strand breaks (SSBs or DSBs, respectively) as well as large chemical 
modifications of DNA bases that are also known as 'bulky' DNA ad ducts (Brooks, 2008; 
Caldecott, 2008; Katyal and McKinnon, 2008) provide a strong argument for a causative 
role of DNA damage in common neurodegenerative disorders. For instance, deficiencies 
of the DSB repair kinase ataxia telangiectasia-mutated protein kinase (ATM) trigger 
delayed neurodegeneration, presumably by blocking the developmental apoptosis of 
newly generated neurons harboring chromosomal abnormalities (Katyal and McKinnon, 
2008). In contrast, the SSBlbulky adducts repair deficits may induce neurodegeneration 
by the progressive and age-dependent accumulation ofunrepaired DNA damage that 
reduces neuronal transcription (Brooks, 2008; Caldecott, 2008; Katyal and McKinnon, 
2008). In the nervous system of whole animals, evidence for linking such genomic 
lesions to transcriptional insufficiency has not yet been reported. 
The nucleolus is a site of ribosomal biogenesis (Grummt, 2003; Drygin et aI., 
2010). That process is initiated by the RNA-Polymerase-l (Poll)-driven transcription of 
nucleolar rRNA genes. Continuous Poll activity is required for maintaining nucleolar 
structure. Consequently, Poll inhibition results in nucleolar disruption, which triggers 
the release of various proteins whose localization is normally restricted to nucleoli. Upon 
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release from the nucleolus some of those proteins lead to the activation of the pro-
apoptotic p53 pathway (Rubbi and Milner, 2003; Yuan et aI., 2005). In proliferating 
cells, this mechanism has been proposed to underlie the cytotoxic effects of several DNA 
damaging anti-cancer drugs (Rubbi and Milner, 2003; Burger et aI., 2010). Work from 
our laboratory has demonstrated that in cultured cortical neurons from newborn rats, the 
DNA damaging DNA-Topoisomerase-l (Topol) inhibitor camptothecin results in Poll 
inhibition and nucleolar stress, which is sufficient to induce p53-dependent apoptosis 
(Kalita et aI., 2008). Hence, nucleolar transcription may serve as a sensor of neuronal 
DNA damage including such camptothecin-induced DNA lesions as SSBs or Topol 
cross-links to DNA. The consequences of activating such a sensing mechanism could be 
p53-mediated apoptosis or a chronic reduction of ribosomal biogenesis if the apoptotic 
response is disabled. 
Etoposide is a widely-used anti-cancer drug that, by inhibiting DNA-
topoisomerase-2 (Top02), induces DSBs, SSBs and Top02-DNA cross-links (Nitiss, 
2009b). In humans, etoposide-containing multidrug chemotherapy has been associated 
with mild cognitive impairment in children and adults (Kaasa et aI., 1988; Mok et aI., 
2005; Whitney et aI., 2008; Riva et aI., 2009). In adult rats, acute neurotoxicity has been 
reported following intracarotid etoposide injections that were combined with the osmotic 
disruption of the blood-brain barrier (BBB) using mannitol (Maeda et aI., 1999; Fortin et 
aI., 2007). To date, there have been no published studies investigating mechanisms of 
etoposide-induced neurotoxicity in whole animals. The current study was performed to 
determine whether nucleolar stress occurs following etoposide-mediated neuronal DNA 
damage and whether such a response is developmentally-restricted. 
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Materials and Methods 
Animals 
Sprague-Dawley rats were purchased from Harlan (Indianapolis, IN, USA). All 
animal experiments strictly followed the protocols that were approved by the Institutional 
Animal Care and Use Committee of the University of Louisville and the NIH guidelines. 
Materials 
The following antibodies and reagents were obtained from commercial sources: 
anti-p53 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti- (phospho-Ser15)-p53 
(Cell Signaling Technology, Danvers, MA, USA); anti-B23 (mouse monoclonal; Santa 
Cruz Biotechnology); anti-(Asp175)-cleaved caspase 3 (rabbit polyclonal; Cell Signaling 
Technology); anti-bromo-deoxyuridine (anti-BrdU, mouse monoclonal; Sigma, St Louis, 
MO, USA); anti-p-galactosidase (rabbit polyclonal anti-p-gal; MP Biomedicals, Solon, 
OH, USA); anti-HA (mouse monoclonal; Roche Diagnostics, Indianapolis, IN, USA), 
anti-p-actin (mouse monoclonal; Sigma); anti-microtubule-associated protein 2 (MAP2) 
(mouse monoclonal; Cell Signaling Technology), and anti-phospho-Ser1981-ATM 
(mouse monoclonal; Cell Signaling Technology); horseradish peroxidase-conjugated 
anti-mouse or anti-rabbit IgG antibodies (Calbiochem, San Diego, CA, USA); Alexa 488-
, Alexa 594-conjugated secondary antibodies, and, Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA, USA); camptothecin, etoposide, ICRF-193, 5-fluorouridine (5FU); 4-
hydroxytamoxifen (4HT) (Sigma). Respective IgG antibodies were used in place of 
primary antibodies as a negative control (data not shown). 
29 
Intracarotid artery injections of etoposide 
Young adult male rats (8-10 weeks old, 200-250 g) were deeply anesthetized 
with an intramuscular injection of3.3 mLlkg mixture containing 25 mg/mL ketamine 
hydrochloride (Abbott Laboratories, Abbott Park, IL, USA), 1.2 mg/mL acepromazine 
maleate (The Butler Company, Dublin, OH, USA), and 0.25 mg/mL xylazine (The Butler 
Company) in 0.9% saline. A midline incision on the neck, longitudinally, to the jugular 
notch was then made. Blunt dissection through the fat pad to separate the sterno-hyoid 
from sterno-mastoid muscles proceeded. An aIm retractor was applied to separate the 
omo-hyoid and sterno-mastoid muscles. The omo-hyoid was lifted, cut and reflected 
laterally. The common carotid was carefully dissected from the vagus and sympathetic 
nerves using a #7 Dumont forceps. A 6.0 size suture was placed under the most caudal 
aspect of the common carotid artery and lifted to temporarily occlude it. A 30 gauge 
needle attached to a syringe via a catheter was inserted into the carotid just rostral to the 
occlusion for injection of 20%D-mannitol and 15 mg/kg etoposide. Three milliliters of 
mannitol was infused over 30 s followed by a 5-min pause prior to the slow infusion of 
1 mL etoposide or 20% dimethylsulfoxide (DMSO) in 0.9% saline. After completion of 
the injection, a microaneurysm clip was applied to the most rostral aspect of the exposed 
common carotid artery. Quick stop powder was applied to quickly promote coagulation 
and the suture was removed. The microaneurysm clip was removed prior to closing the 
incision with wound clips. 
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Intracerebroventricular injection 
Rat pups received injections at postnatal day 7 (P7) based on a previously 
described method (Han and Holtzman, 2000). The injections of 5 JlL artificial CSF 
(126 mM NaCI, 25 mM NaHC03, 25 mM glucose, 1.25 mM NaH2P04, 2.5 mM KCI, 
I mM MgCI) I 20%DMSO ± 10 nmoles etoposide were made with a Hamilton needle 
inserted into the left lateral ventricle at the following coordinates: 1.5 mm rostral- and 
1.5 mm lateral to lambda (incorrectly named Bregma in (Han and Holtzman, 2000), Dr 
David Holtzman, personal communication), 2 mm deep from the skull surface. Lambda 
was readily identified by the underlying venous sinuses which were visualized by shining 
light from two focal sources placed on either side of the head (D. Holtzman, personal 
communication). After injection, animals were placed back with their mother. 
Cell culture and transfection 
Cortical neurons were isolated from newborn Sprague-Dawley rats at postnatal 
day 0 as described previously (Habas et aI., 2006). Neurons were cultured in basal 
medium Eagle supplemented with 10% heat-inactivated bovine calf serum (Hyclone, 
Logan, UT, USA), 35 mM glucose, 1 mM L-glutamine, 100 U/mL of penicillin and 
0.1 mglmL streptomycin or Neurobasal AlB27 medium (Invitrogen). On day in vitro 2 
(DIV2), 2.5 JlM cytosine arabinoside was added to cultures to inhibit the proliferation of 
non-neuronal cells. Cells were used for experiments on DIV5-6 unless indicated 
otherwise. 
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Drug treatment of cultured neurons 
For treating cultured cells, etoposide, camptothecin, ICRF-193 or 4HT were 
dissolved in DMSO or methanol, respectively. The final media concentration of the 
solvents was 0.2%. 
RNA isolation and quantitative RT-PCR 
Following CO2 euthanasia, the entire rat neocortex was harvested and 
immediately frozen on dry ice. Tissue RNA extraction was done following 
homogenization with a pestle grinder (Fisherbrand; Fisher Scientific, Pittsburgh, PA, 
USA) in 1 mL TRI Reagent (Sigma) at 4°C. Cultured cell RNA was isolated from 
5 x 106 cells/sample using TRI Reagent. The random hexamers-primed eDNA synthesis, 
quantitative RT-PCR, and the ~~ct-based analysis of 45S pre-rRNAl18S rRNA levels 
were done as described previously (Kalita et aI., 2008). 
Immunofluorescence 
Deeply anaesthetized rats were transcardially perfused with ice cold PBS, and 
then with 4% paraformaldehyde in PBS. Following 24 h post-fixation, brains were 
cryoprotected for up to 72 h in 30% sucrose and sectioned on a cryostat at 25 ~m sections 
(P7 rats) or 30 ~m sections (adult rats), and mounted on slides. For B23 staining, epitope 
rescue was carried out in 10 mM sodium citrate buffer, 0.05%Tween, pH 6.0 for 20 min 
at 90°C. Then, sections were incubated in blocking solution [3% bovine serum albumin, 
10% normal goat serum in PBS/0.1 % Triton-Xl 00 (PBST), 1 h] followed by primary and 
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secondary antibodies (anti-B23, 1 :100,48 h at 4°C and anti-mouse-IgG-Alexa-488, 
1: 100, 4 h at 20°C, respectively). Activated caspase 3 (Asp 175) immunostaining was 
performed following a standard protocol. Briefly, after 1 h blocking (3% bovine serum 
albumin, 5% normal goat serum in PBST), sections were incubated with an antibody 
specific for the cleaved, activated caspase 3 (1 : 100, over night at 4°C) followed by an 
Alexa-488-labled secondary antibody (1 : 100, 1 h at 20°C). Nuclei were visualized by 
Hoescht-33258. Then, sections were covered with coverslips that were mounted using 
Fluoromount G (Southern Biotech, Birmingham, AL, USA). 
Image acquisition and analysis 
Images were captured using the Nikon Eclipse TE2000-S or the Zeiss 
AxioObserver inverted microscopes with MetaMorph or Axio Vision software, 
respectively. Fluorescent exposure rates were kept consistent across all conditions by 
fluorescent filter. Images were exported as TIF files with and without scale bar 
annotations. Both the annotated and unannotated TIF images were further scaled in 
Photoshop7 (Adobe Systems Incorporated, San Jose, CA, USA) and a line of appropriate 
font was applied to the unannotated TIF that matched the size of the annotated TIF in 
Adobe Illustrator 10 (Adobe). 
Evaluation of apoptosis 
Apoptosis was evaluated by nuclear morphology. Cells were stained with 
Hoechst 33258 and anti-cleaved caspase-3 observed using fluorescent microscopy. Cells 
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with condensed or fragmented nuclei were scored as apoptotic. Though quantifications 
were not provided in figures shown in this thesis, in vitro quantification provided in the 
published work were conducted by counting both Hoechst 33258-stained apoptotic 
bodies and live nuclei. Total apoptotic nuclei were divided by the summed total of 
counted nuclei (healthy and apoptotic) to determine the apoptotic ratio. No less than 300 
cells were counted and all areas of the stained coverslip were included in the calculations. 
Statistical analysis 
Statistical analysis of the data was performed using one-way ANOV A. Error bars were 
expressed as standard errors of the mean. 
Results 
Nucleolar stress in cortical neurons of etoposide-treated rats 
To investigate the nucleolar consequences of etoposide-induced DNA damage in 
adult rats, we performed intracarotid injections of 15 mg/kg etoposide immediately after 
osmotic BBB disruption with 20% mannitol. Although such delivery may reach various 
parts of the brain, we focused our analysis on the neocortex. Four hours after etoposide-
injection, the neocortical45S pre-rRNAll8S rRNA ratio decreased to 0.51-fold of 
vehicle-treated controls (Fig. 4A, p < 0.05). As 45S pre-rRNA is the primary Poll 
transcript that is rapidly processed to mature rRNA species, including 18S rRNA, the 
declining 45SI18S ratio indicates Poll inhibition (Kalita et aI., 2008). This conclusion is 
further supported by the immunostaining for the nucleolar marker B23/nucleophosmin 
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(Fig. 4B), as nucleolar localization of that protein depends on active Poll (Rubbi and 
Milner, 2003; Kalita et aI., 2008). Hence, upon Poll inhibition, B23 is released from the 
nucleoli and diffuses throughout the nucleoplasm (Rubbi and Milner, 2003; Kalita et aI., 
2008). In vehicle-, but not etoposide-injected rats, B23 immunostaining was 
concentrated in the nucleoli of neocortical cells (Fig. 4B). Six hours after etoposide 
treatment, B23 immunostaining became uniformly distributed in the nucleoplasm of 
those cells, suggesting that they are under nucleolar stress (Fig. 4B). The nucleolar stress 
was present in virtually all neocortical cells (Fig. 4B, and data not shown). Hence, in 
cortical neurons of adult rats, nucleolar disruption is a response to the DNA damaging 
drug etoposide. 
To determine whether such a response is also present in the developing brain, 7-day 
old rats were administered 10 nmoles of etoposide by a single injection into the right 
lateral ventricle. After 4 h, the declining ratio of 45S pre-rRNAl18S rRNA indicated 
Poll inhibition in the ipsilateral neocortex of etoposide-treated animals (Fig. 5A). In 
addition, etoposide induced a partial release of nucleolar B23 in almost all analyzed cells 
from the ispilateral neocortex (Fig. 5B). Therefore, the etoposide-induced nucleolar 





















Figure 4: Nucleolar disruption in the neocortex of etoposide-treated adult rats. 
Rats were infused with 0 or 15 mg/kg etoposide that was administered into the right 
intracarotid artery immediately after BBB disruption with 20% d-mannitol. (A) At 4 h 
after etoposide treatment, reduced nucleolar transcription was observed in the ipsilateral 
neocortex as indicated by the declining expression ratio of the primary nucleolar rRNA 
transcript (45S pre-rRNA) to the mature 18S rRNA. The rRNA levels were determined 
by quantitative real-time peR; data are mean ± SE of four animals per group; *p < 0.05. 
(B) At 6 h after etoposide treatment, nucleolar stress was observed throughout the 
ipsilateral neocortex as indicated by the loss of nucleolar immunofluorescence of 
nucleolphosminIB23. B23, which under control conditions was concentrated in nucleoli 
(arrows), displayed a diffused staining pattern throughout the nucleoplasm in etoposide-
infused rats (arrowheads). Note that cells with nucleolar stress had normal chromatin 
structure as visualized by counter-staining with Hoechst-33258. Representative 
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photomicrographs of cortical layer IV-VI are shown; similar effects of etoposide on B23 























Figure 5: Nucleolar disruption in the neocortex of etoposide-treated newborn rats. 
At postnatal day 7 (P7), rats received 0 or 10 nmoles etoposide that was administered by 
an injection into the right lateral ventricle. (A) Four hours after etoposide injection, 
nucleolar transcription was suppressed in the ipsilateral neocortex. Data are means ± SE 
of four animals per group; **p < 0.01. (B) Six hours after etoposide injection, nucleolar 
stress was present in the ipsilateral neocortex. Reduced nucleolar B23 staining together 
with its diffused appearance throughout the nucleoplasm was observed in most 
neocortical cells (arrowheads). B23 under control conditions was concentrated in 
nucleoli (arrows) . Note that cells with nucleolar stress had normal chromatin structure as 
visualized by counter-staining with Hoechst-33258 . Representative photomicrographs of 
cortical layer IV-VI are shown; similar effects of etoposide on B23 localization were 
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observed in four animals. 
Etoposide-induced apoptosis is developmentally-restricted 
Conversely, etoposide triggered apoptosis in developing, but not mature cortical 
neurons. In the neocortex of vehicle-injected neonates, immunostaining for the activated 
form of caspase 3 revealed rare apoptotic cells (up to 2-3 cells/section) (Fig. 6A-C, and 
data not shown). In contrast, numerous cells with active caspase 3 were observed in the 
neocortex of etoposide-injected neonates at 6 h post-injection (Fig. 6D, F, H). Such cells 
were most frequent in the proximity of the injection site and spread throughout all 
cortical layers. In addition to active caspase 3, they often displayed apoptotic chromatin 
condensation (Fig. 6E, G). The morphology of some active caspase 3-positive cells 
revealed neuronal features, including pyramidal perikaria and neurites (Fig. 6D, F). In 
addition, cells with apoptotic rounding of the shrunken cell bodies were also present (Fig. 
6H). Although most apoptotic cells were identified in the ipsilateral neocortex, their 
increased incidence was also noticed on the contralateral side (data not shown). After 
24 h, few apoptotic cells were present and tissue destruction was observed around the 
etoposide-, but not the vehicle injection site (data not shown). Neither caspase 3 
activation nor apoptotic chromatin condensation was present in the neocortex of 
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Figure 6: Etoposide-induced apoptosis in the neocortex of the neonate, but not the 
adult rats. 
Neonate (P7) (A-H) or adult rats (I-N) were treated as described for Figs 5 and 4, 
respectively. Six hours after etoposide (Etop) administration apoptosis was identified by 
the presence of immunofluorescence for activated caspase 3 and/or 
condensation/fragmentation of nuclear chromatin that was visualized by counter-staining 
with Hoechst-33258. Photomicrographs of the ipsilateral neocortex are shown. Three 
animals were analyzed for each condition. Cortical layers are indicated by roman 
numerals. (A-H) Activated caspase 3 and apoptotic chromatin rearrangements in 
neocortical cells of etoposide-treated neonates (arrows). Presence of active caspase 3 in 
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neurites suggests neuronal identity of many apoptotic cells (arrowheads). (I-N) Absence 
of apoptotic cells from the neocortex of etoposide-treated adult rats. 
The pronounced apoptotic response was also present in the hippocampi of the 
etoposide-treated neonatal rats (Fig. 7D-F). Apoptotic cells were most frequent in the 
granule cell layer of the ipsilateral dentate gyrus (Fig. 7D-F). Increased frequency of 
such cells was also observed on the contralateral side (data not shown). Finally, some 
caspase 3-positive cells appeared in the pyramidal cell layer of the ipsilateral 
hippocampus (data not shown). As in the neocortex, no evidence for etoposide-induced 
apoptosis was found in the adult hippocampi or other analyzed structures of the adult rat 
brain (Fig. 7G-L, and data not shown). Therefore, unlike nucleolar stress, apoptosis is a 
developmentally restricted response to etoposide-induced DNA damage. 
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Figure 7 
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Figure 7: Etoposide-induced apoptosis in the hippocampus of the neonate, but not 
the adult rats. 
Neonate (P7) (A-F) or adult rats (G-L) were treated as described for Figs. 5 and 4, 
respectively. Six hours after etoposide (Etop) administration apoptosis was identified as 
in Fig. 6. Photomicrographs of the ipsilateral hippocampi are shown. Three animals 
were analyzed for each condition. (A-F) Etoposide-induced activation of caspase 3, and 
apoptotic chromatin rearrangements in granule cells of the neonate dentate gyrus 
(arrows). (G-L) Absence of apoptotic cells from the dentate gyrus of etoposide-treated 
adult rats. 
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Etoposide-induced damage of neuronal DNA causes nucleolar disruption 
As in whole animal studies, the neuronal effects of a drug may be indirect, 
cultured cortical neurons from newborn rats were used to test whether nucleolar 
disruption is caused by etoposide-induced damage of neuronal DNA. In neurons that 
were incubated for 8 h with etoposide, the 45SI18S rRNA ratio decreased in an etoposide 
concentration-dependent manner (Fig. 8). Declines to 0.64- or 0.55-fold of vehicle-
treated controls were triggered with 25- or 50 11M etoposide, respectively, indicating Poll 
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Figure 8: Etoposide-induced nucleolar stress in cultured cortical neurons from 
newborn rats. 
At DIV5, rat cortical neurons were treated with etoposide for 8 h as indicated. At 
etoposide concentrations of25- or 50- but not 10 JiM, the ratios of 45S pre-rRNAl18S 
rRNA levels declined, suggesting inhibition of Poll-mediated transcription. Data 
represents mean ± SE of three independent experiments; *p < 0.05; **p < 0.01. 
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Discussion 
In this study, we obtained evidence that the DNA damaging drug etoposide 
inhibits Poll-mediated transcription triggering nucleolar stress in both developing and 
mature cortical neurons of whole rats. That contrasts with neuronal apoptosis, whose 
induction by etoposide appears developmentally-restricted. Hence, we propose that 
nucleolar disruption is a DNA damage response that occurs in both young and adult 
neurons and, as such, may contribute to neurotoxic consequences DNA strand breaks that 
are associated with neurodegenerative diseases. 
Etoposide was used to investigate the nucleolar effects of neuronal DNA damage 
in whole animals. For adult rat studies, we applied that agent by intracarotid injection 
that was performed immediately after osmotic disruption of the BBB. That method was 
chosen because of its demonstrated effectiveness in delivering etoposide to the adult 
animal- or human brain (Maeda et aI., 1999; Fortin et aI., 2007). Using that technique, 
we showed nucleolar disruption, but no apoptosis in the ipsilateral cortices of rats 
receiving 15 mg/kg etoposide. By 5 h after injecting such a dose, all animals displayed 
signs of systemic drug toxicity including hypoactivity and slowed breathing. Therefore, 
it is possible that the disruption of nucleolar B23 at 6 h after treatment may be a 
secondary response to such toxicity. However, Poll inhibition was also observed in all 
animals at 4 h post-injection when the first signs of systemic toxicity were present in five 
of eight treated rats. In addition, nucleolar stress was induced in cortical neurons of 
young animals that received etoposide by intracerebroventricular injection and remained 
in excellent health for at least 24 h post-treatment. Finally, in cultured cortical neurons 
that were directly exposed to etoposide, nucleolar disruption was present. Therefore, the 
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etoposide effects on the nucleolar integrity of cortical neurons are likely associated with 
its direct genotoxic actions in those cells. Indeed, in the developing rat neocortex, we 
observed etoposide-induced nucleolar stress and apoptosis without any signs of major 
systemic toxicity. Hence, intracerebroventricular injection of etoposide provides a 
convenient model to investigate consequences of neuronal DNA damage in whole rat 
pups. 
As excessive accumulation of DNA strand breaks is associated with neuronal 
dysfunctionlneurodegeneration. Nucleolar stress may be among the neurotoxic effector 
mechanisms that are triggered by such genotoxic lesions. While in common 
neurodegenerative diseases the genotoxic frequency will unlikely reach the levels that 
will be needed for a complete block of Poll-driven transcription and the consequent 
disruption of the nucleolar structure, they may reduce ribosomal biogenesis to such levels 
that will be insufficient to maintain fully functional protein synthesis machinery, thereby 
leading to neuronal atrophy including loss of synapses. Of note, reduced ribosomal 
biogenesis is suggested in the Alzheimer's Disease-associated cerebro-cortical pathology 
that also involves oxidative DNA damage (Ding et aI., 2005; Honda et aI., 2005; 
Markesbery and Lovell, 2006). Therefore, DNA damage-induced nucleolar stress may 
contribute to Alzheimer's Disease. 
In conclusion, our results demonstrate that Poll inhibition is a neuronal response 
to DNA damage that is not developmentally restricted, while neuronal apoptosis is a 
developmentally-restricted DNA damage response. Hence, nucleolar stress may be one 
of the neurotoxic effector mechanisms of DNA damage in the adult/aging brain. 
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REGULATION OF RNA POLYMERASE-I-MEDIATED TRANSCRIPTION BY 
ATAXIA TELEANGIECTASIA MUTATED (ATM) 
Introduction 
Ataxia-telangiectasia mutated (ATM) is a protein kinase that belongs to the PI3K 
family including such members as mTOR, PI3K, DNA-PK, ATR and SMG-l. ATM is 
activated by DNA double-stranded break (DSB) damage, thereby playing an important 
role in the DNA damage response (Herzog et aI., 1998; Gatti et aI., 2001; Biton et aI., 
2008; Lavin, 2008). Its absence or insufficiency causes the autosomal recessive disorder 
Ataxia-telangiectasia (A-T), which is characterized by cancer predisposition, 
immunodeficiency, and neurodegeneration leading to cerebellar ataxia (Lavin and Shiloh, 
1997; Gatti et aI., 2001; McKinnon, 2004). The A-T associated neurodegeneration 
includes Purkinje and granule cell loss in the cerebellum and may also be present in other 
brain structures such as forebrain, brain stem and spinal cord (Lavin and Shiloh, 1997; 
Biton et aI., 2008; Li et aI., 2011). The mechanisms ofneurodegeneration in A-T patients 
remain unknown. 
There are several functions of ATM that appear unrelated to its involvement in 
the DNA damage response. In addition to mTOR, ATM directly phosphorylates 4E-BPI 
increasing translation in insulin-stimulated cells (Yang and Kastan, 2000). Similarly 
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ATM has been shown to activate AKT to promote cellular survival (Li and Yang, 2010). 
The CREB-dependent differentiation of human SH-SY5Y neuroblastoma cells also 
requires ATM (Fernandes et aI., 2007). At the synapse, ATM regulates neurotransmitter 
release, contributing to synaptic plasticity (Li et aI., 2009). Such multi-functionality of 
A TM is supported by its widespread distribution throughout the cell including the 
nucleus, nucleolus, vesicles and cytoplasm (Gorodetsky et aI., 2007; Lavin, 2008; Li et 
aI.,2009). Indeed, the functional versatility of ATM may explain the complex pathology 
of A-T. 
The nucleolus is a transcription-dependent structure that contains clustered 
repeats of the 45S rRNA genes (ribosomal DNA, rDNA). The transcription ofrDNA by 
RNA Polymerase-I (Poll) is the first step of ribosomal biogenesis (Grummt, 2003; 
Drygin et aI., 2010). By controlling ribosomal biogenesis, Poll activity determines cell 
proliferation and cell growth. Therefore, Poll is tightly regulated to adjust ribosomal 
biogenesis to cellular needs and resources (Grummt, 2003). Indeed, cellular growth, 
including neurite outgrowth, requires growth factor-dependent activation of Poll that is 
mediated by ERK1I2- and mTOR signaling pathways (Grummt, 2003; Mayer et aI., 
2004; Drygin et aI., 2010; Gomes et aI., 2011). Conversely, Poll is inhibited by cellular 
injury including DNA damage (Mayer and Grummt, 2005; Kruhlak et aI., 2007; Kalita et 
aI., 2008; Pietrzak et aI., 20llb). Finally, insufficiency of nucleolar transcription to 
replenish neuronal ribosomes has been proposed as a mechanism of neurodegeneration 
(Hetman & Pietrzak, accepted, TINS). 
While searching for DNA damaging agents that inhibit neuronal Poll, we 
observed its unexpected stimulation in response to DNA topoisomerase-II inhibitors that 
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was A TM dependent. Therefore, we conducted further experiments to detennine whether 
(i) regulation of Poll by stimuli promoting neuronal growth required ATM, (ii) ATM was 
necessary for neuronal growth and (iii) ATM regulated Poll in immortalized proliferating 
cells. 
Materials and Methods 
Animals 
All animal experiments strictly followed the protocols that were approved by the 
Institutional Animal Care and Use Committee of the University of Louisville and the 
NIH guidelines. Newborn Sprague-Dawley rats at PO were used for cell culture. 
Postnatal day 7 rats were used for in vivo studies. Cerebellar and cortical A TM-1- mouse 
tissues were from a previously described line of ATM knock out mice (Herzog et aI., 
1998). 
Materials 
The following reagents were obtained from the indicated commercial sources: 
mouse monoclonal anti-B23 antibody and mouse monoclonal anti-ATM antibody, Santa 
Cruz Biotechnology, Inc. (Santa Cruz, CA); 5-ethynyl uridine (5-EU, Berry and 
Associates, Dexter, MI); Actin-RFP, Alexa 488-, Alexa 594-conjugated secondary 
antibodies, Oregon Green®-6-carboxamido-(6-azidohexanyl) triethylammonium salt, 
(Oregon Green®-azide), and Lipofectamine 2000, Invitrogen (Carlsbad, CA, USA); 
BDNF (Alomone Labs, Jerusalem, Israel); anti-ERK1I2 antibodies, anti-phospho-
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(S1981)-ATM mouse monoclonal antibody, anti-phospho-(S473)-AKT rabbit polyclonal 
antibody, anti-phospho-(T389)-RPS6 mouse monoclonal, anti-RPS6 rabbit monoclonal, 
anti-MAP2 rabbit polyclonal, Cell Signaling (Beverly, MA, USA), antiphospho-ERK1I2 
antibody (anti-ACTIVE_ MAPK pAb), Promega (Madison, WI, USA); horseradish 
peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies and L Y294002, 
Calbiochem (San Diego, CA, USA). KU55933, SR-95531, and KU0063794, Tocris 
(Ballwin, MO, USA). All other reagents were purchased from Sigma (St. Louis, MO). 
Respective IgG antibodies were used in place of primary antibodies as a negative control 
and resulted in background staining (data not shown). 
Cell culture 
Cortical or hippocampal neurons were prepared from newborn Sprague-Dawley 
rats at PO as previously described (Habas et aI., 2006). Briefly, the culture medium was 
Basal Medium Eagle (BME) supplemented with 10% heat-inactivated bovine calf serum 
(Hyclone, Logan, UT), 35 mM glucose, 1 mM L-glutamine, 100 U/mL of penicillin and 
0.1 mg/mL streptomycin. Cytosine arabinoside (2.5 11M) was added to cultures on the 
second day after seeding (day in vitro 2, DIV2) to inhibit the proliferation of non-
neuronal cells. Cells were used for experiments at DIV 5-6, with the exception of 
neuronal activity-dependent experiments and morphogenesis experiments. Neuronal 
activity experiments were conducted on DIV 8 to allow for neurons to develop a network 
of processes with synaptic contacts and express functional NMDA-type and AMPA 
glutamate receptors (Papadia et aI., 2005). For morphogenesis experiments neurons 
were transfected on DIV 3, treated on DIV 4 and fixed 24 h later (DIV5). 
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Serum starvation of cultured cortical neurons. Serum starvation of cultured 
cortical neurons has been described previously (Kharebava et aI., 2008). Briefly, on DIV 
5-6, cells were washed twice with serum free BME and placed in BME medium 
containing MK-80 I and AraC. Two hours later, BDNF (lOng/mL) and/or inhibitors were 
added to the medium for an additional 2 h. 
Serum stimulation of cell lines. Immortalized cells were cultured in DMEM 
supplemented with 10% fetal bovine serum (FBS) and 1 % penicillin/streptomycin and 
plated at a density of approximately 2 X 106 /35 mm dish. Serum starvation was 
conducted by washing cells twice with serum free DMEM followed by placement in 
serum free DMEM supplemented with antibiotics for 12-14 h. Then, cells were placed 
back in the full growth medium in the presence or absence ofKU55933. 
Intracerebroventricular injection 
ICV injection into the P7 rat has been described previously (Pietrzak et aI., 
2011 b). Briefly, injections of 5 /-lL artificial cerebrospinal fluid (aCSF: 126 mM NaCI, 25 
mM NaHC03, 25 mM Glucose, 1.25 mM NaH2P04, 2.5 mM KCI, 1 mM MgCh) /20% 
DMSO ± pharmacological agent (etoposide, ICRF-193, KU55933) were made with a 
Hamilton needle inserted into the right lateral ventricle at the following coordinates: 1.5 
mm rostral- and 1.5 mm lateral to lambda, 2 mm deep from the skull surface. Lambda 
was readily identified by the underlying venous sinuses which were visualized by shining 
light from two focal sources placed on either side of the head, or one light source beneath 
the chin. After injection, animals were placed back with their mother. 
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Transfection of DNA 
An expression plasmid for alpha-acti Red Fluorescent Protein (alpha-actin RFP) 
was transiently transfected into cortical neurons on DIV 3. First, the conditioned medium 
was removed and saved; Cells were then placed in serum-free basal Eagle's medium 
(Sigma) supplemented with 1.5 IlLlmL 20mM glucose containing 0.5 Ilg of DNA mixed 
with 1.5 ilL of Lipofectamine/weli. After a 40 min incubation at 5% CO2 and 37 °C, the 
transfection medium was replaced with conditioned medium. Cells were fixed for 15-30 
minutes at room temperature and immunostained 2 days after transfection. 
Image acquisition/Morphogenesis 
Images were captured using the Zeiss AxioObserver inverted microscopes with 
MetaMorph or AxioVision software, respectively. Fluorescent exposure rates were kept 
consistent across all conditions by fluorescent filter. Images were exported as TIF files 
with and without scale bar annotations. Both the annotated and unannotated TIF images 
were further scaled in Photoshop7 (Adobe Systems Incorporated, San Jose, CA, USA) 
and a line of appropriate font was applied to the unannotated TIF that matched the size of 
the annotated TIF in Adobe Illustrator 10 (Adobe). 
Morphogenesis images were captured on Zeiss Axio Observer inverted 
microscope and AxioVision software at 20X magnification. NeuronStudio (Weame et 
aI., 2005; Rodriguez et aI., 2008) was used to hand-trace neurites from the soma. An 
average of 13 representative cell images were analyzed per condition per culture. The 
researcher collecting images and conducting the tracing was blinded to each of the 
experimental conditions while conducting this work. Images were accessed by the 
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presence of healthy nuclei, evaluated by Hoechst 33258 nuclear staining, alpha-actinRFP-
positive fluorescence, and the absence of neurite beading (an indicator of progressing 
degeneration) . 
Drug treatment 
Etoposide, ICRF-193, LY294002, U0126, KU55933, KU0063794, MK-801, 
SR95531 (Gabazine), and 4-AP were dissolved in dimethyl sulfoxide (DMSO). 
Inhibitors were added to the medium 20 minutes prior to stimulation by etoposide, ICRF-
193, BDNF or Gaba/4-AP. The final media concentration of the solvents was 0.2%. 
In situ run-on assay 
The RNA precursor, 5-EU, was used as described previously (Gomes et aI., 
2011). Briefly, to label nascent RNA, glass coverslip-cultured cells were incubated with 
1 mM 5-EU for one hour (37°C, 5% CO2) followed by fixation with 4% 
paraformaldehyde. Co-immunofluorescence for the nucleolar marker B23 was performed 
according to standard protocols. Following incubations with the secondary antibodies, 
the 5-EU-labeled nascent RNA was detected using the previously described "click" 
chemistry methodology (Jao and Salic, 2008). The "click" buffer (1 M tris-HC1, pH 8.5; 
100 mM CUS04, 0.5 M ascorbic acid, 5 mM Oregon Green® azide in DEPC-treated 
water) was applied for 30 min followed by a wash with PBS and mounting of the 
coverslips on to slides. The integrated brightness density of 5-EU was calculated in the 
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B23-positive nucleoli using the NIH freeware Image-J. For each cell, nucleolar signal 
was normalized against the 5-EU staining in the whole nucleus. 
Western blot analysis 
Western blot analyses were performed using standard protocols and illuminated 
with Luminol. Primary antibodies were used at 1: 1 000 and horseradish peroxidase-
conjugated mouse or rabbit secondary was used at 1: 10,000 (Hetman et aI., 2002). 
Immunofluorescence 
Deeply anaesthetized rats were transcardially perfused with ice cold PBS 
followed by 4% paraformaldehyde in PBS. Following 24 h post-fixation, brains were 
cryoprotected for up to 72 h in 30% sucrose and sectioned on a cryostat at 25 /lm 
sections, and mounted on slides. Sections were membrane-permeabilized using NP-40 
0.5% in PBS. Sections were then incubated in blocking solution (3% bovine serum 
albumin, 10% normal goat serum in PBS/O.1 % Triton-Xl 00 (PBST), 1 h) followed by 
primary and secondary antibodies (anti-ATM, 1:100, overnight at 4°C and anti-mouse-
IgG-Alexa-594 or Alexa-488, 1: 100, 1 h at room temperature, respectively). 
Immunocytochemistry for cortical neurons was conducted similarly and concentrations as 
follows: anti-ATM, 1: 1 000, anti-mouse IgG-Alexa-594 or 488, 1: 1000. Nuclei were 
visualized by Hoescht-33258. Then, sections were covered with coverslips that were 
mounted using Fluoromount G (Southern Biotech, Birmingham, AL, USA). 
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RNA isolation and quantitative Real-Time peR 
Following CO2 euthanasia, the entire rat neocortex was harvested and 
immediately frozen on dry ice. Tissue RNA extraction was done following 
homogenization with a pestle grinder (Fisherbrand; Fisher Scientific, Pittsburgh, P A, 
USA) in I mL TRI Reagent (Sigma) at 4°C. Cultured cell RNA was isolated from 
5 x 106 cells/sample using TRI Reagent. The random hexamers-primed eDNA synthesis, 
quantitative RT-PCR, and the ~~ct-based analysis of 45S pre-rRNAlI8S rRNA levels 
were done as previously described (Pietrzak et aI., 20IIb). 
Oligonucleotides 
Primers for rat 45S pre-rRNA and 18S rRNA have been described previously 
(Pietrzak et aI., 20Ilb). Rat and mouse I8S rRNA share sequence homology. Primers for 
mouse pre-rRNA were as follows: 
45S forward: 5'-CTC ACC CCC GGT TTG TCC T-3'; reverse: 5'-CTA CCT GGC AGG 
ATC AAC CA-3' 
18S forward: 5'-TCA ACT TTC GAT GGT AGT CGC CGT-3'; reverse: 5'-TTC TTG 
GAT GTG GTA GCC GTT TCT-3' 
Primers for human pre-rRN A and 18S rRNA were as follows: 
45S forward: 5'-GTC AGC CCT CGA CAC AAG G-3'; reverse: 5'-GGG AGG AAG 
ACG AAC GGA AG-3' 
I8S forward: 5'-TCA ACT TTC GAT GGT AGT CGC CGT-3'; reverse: 5'-TTC TTG 
GAT GTG GTA GCC GTT TCT-3' 
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Results 
DNA topoisomerase-II inhibitors induce nucleolar transcription through the activation 
ofATM 
Etoposide is a widely-used anti-cancer drug that inhibits DNA-topoisomerase-2 
(Top02) and thereby induces DSBs, SSBs and Top02-DNA cross-links (Nitiss, 2009a). 
Etoposide has previously been shown to suppress Poll-mediated transcription at high 
concentrations in mouse embryonic fibroblasts (MEFs) (Kruhlak et aI., 2007). Similarly, 
etoposide induces nucleolar stress in neurons at concentrations exceeding 1 0 ~M for 8 h 
(Pietrzak et aI., 20 11 b). While evaluating effects of lower concentrations of etoposide we 
were surprised to observe stimulation of Poll. Thus, levels ofpre-rRNA increased in 
cortical neurons exposed to 0.3 and 1 ~M etoposide for 4 h (Fig. 9A). This finding led us 
to test another Top02 inhibitor, ICRF-193, whose potential to induce DNA strand breaks 
is lower than that of etoposide (Hajji et aI., 2003; Park and Avraham, 2006; Robinson et 
aI., 2007; Nitiss, 2009b). Increased pre-rRNA levels were observed in cortical neurons 
that were exposed to 25 ~M ICRF-193 for 4 h (Fig. 9B). We observed a similar 
induction of Poll-mediated transcription in the ipsilateral cortices of neonate rats at 4 h 
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Figure 9: Topoisomerase-II inhibitors increase neuronal nucleolar transcription. 
A-B, Cultured cortical neurons were treated as indicated for 4 h. (A) Low concentrations 
of etoposide increased the 45S pre-rRNAl18S rRNA ratio. Nucleolar transcription was 
suppressed at concentrations above 10 )-lM. (B) Increased levels of 45S pre-rRNA after 
treatment with 25 )-lM ICRF-193. C-D, P7 rat pups (3 animals/condition) received 
injections of either etoposide (C), or ICRF-193 (D) into the right lateral ventricle; after 4 
h, ipsilateral cortices were dissected and analyzed. In all graphs, error bars indicate 
SEM; *, p<O.05; **, p<O.Ol; in A-B, three independent cultures were analyzed. 
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As in non-neuronal systems, both etoposide and ICRF-193 activate DNA damage 
signaling including ATM. We wondered whether activation of Poll in neurons treated 
with these drugs is regulated by ATM. First, we confirmed that 1 and 10 flM etoposide 
(Fig. lOA), as well as 10 and 25 flM ICRF-193 (Fig. lOB), increased ATM 
autophosphorylation at S 1981 suggesting activation of this kinase. Importantly, 
concentrations that caused A TM activation overlapped with those activating Poll. We 
then used the ATM-specific inhibitor (Hickson et aI., 2004; Li and Yang, 2010), 
KU55933 (K5), to test the Poll effects ofTop2 inhibitors upon blocking ATM. At 10 
flM, K5 suppressed the etoposide-induced autophosphorylation of ATM at S 1981 (Fig. 
1OC). It also suppressed Poll activation either by etoposide (1 flM) (Fig. lOD) or ICRF-
193 (25 flM) (Fig. lOE). Finally, the etoposide-mediated induction of Poll-driven 
transcription in the nucleolus and its prevention by the ATM inhibitor were confirmed 
using in situ run-on assay with the RNA precursor, 5-ethynyluridine (5-EU) followed by 
immunostaining for the nucleolar marker B23 (Fig. 10F,G). These results also confirmed 
that at low concentrations of etoposide which activated Poll, nucleolar integrity was not 
affected. Together, these observations suggest that in Top02-inhibited neurons ATM 
activation stimulates Poll-driven transcription. 
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Figure 10 
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Figure 10: Poll-mediated transcription of cultured cortical neurons increases in 
response to ATM activation by Topo2 inhibitors. 
A-B, Etoposide and ICRF-193 activated ATM as indicated by its increased 
autophosphorylation at the S 1981 residue. C, The specific ATM inhibitor, KU55933 
(K5), attenuated the etoposide-mediated activation of ATM. (A-C) representative 
Western blots are shown. Equal protein content on the blots was ensured by reprobing 
them for either total MAP2, or running a new gel with the equal protein concentrations 
and probing for AKT. D-E, ATM inhibition with 10 11M K5 attenuated the effects of 
Top02 blockers on neuronal nucleolar transcription. Averages of3 independent 
experiments are shown. F-G, Etoposide-mediated accumulation of nascent RNA in the 
nucleolus is prevented by K5. Increased nascent RNA levels in neuronal nuclei were 
observed after etoposide treatment, and were reduced following ATM inhibition. 
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Cortical neurons were treated with vehicle, 1 11M etoposide, or co-treated with etoposide 
1 11M and 10 11M KS for 3 h followed by 1 h incubation with the RNA precursor S-
ethynyluridine (S-EU, 1 mM). After fixation and co-immunofluorescence for the 
nucleolar marker B23, nascent RNA was visualized using "click" chemistry (see methods 
for more details). Etoposide increased the ratio between nucleolar- and nuclear- nascent 
RNA levels, whereas KS abolished that effect. For nascent RNA quantifications, the 
nucleolar compartment was defined by B23 immunofluorescence. (G) Data are averages 
of at least 40 randomly selected individual neurons/condition from 3 independent 
experiments. In all graphs, error bars indicate SEM; *, p<O.OS; **, p<O.O 1. 
The role of ATM in maintaining neuronal Poll activity under basal conditions 
To further evaluate the involvement of ATM in regulating nucleolar transcription 
in neurons, we first characterized effects of its pharmacological inhibitor KS on other 
signaling pathways that were previously implicated in activation of Poll in response to 
growth factors. We treated dissociated cortical neurons for 4 h with KS as well as 
inhibitors ofERK1I2- (UOI26), PI3K- (LY29004, (LY)), and mTOR- (KU0063794, 
(K006)) pathways. We then evaluated the activation status ofERK1I2, and mTORcl by 
monitoring phosphorylations ofERK1I2 and RPS6 (T183/YI8S, S23S/236, respectively). 
In addition, phosphorylation of AKT at S473 was studied as it may be carried out by 
ATM itself or by DNA-PK or mTORc2 (Fig. lIA). Basal ATM inhibition did not affect 
ERK1I2, and decreased the phosphorylation of AKT, and RPS6 compared to vehicle. 
These results support the notion that ATM contributes to signaling networks that mediate 
growth factor responses. Consistent with that, ATM inhibition reduced basal pre-rRNA 
levels to a similar extent as did inhibition of ERK 112 , PI3K, and mTOR (Fig. lIB). In 
addition, intracerebroventricular injection ofKS reduced basal pre-rRNA levels in the 
ipsilateral cortex of neonate rats (Fig. 11 C). To identify whether ATM inhibition 
affected global transcription, we again employed the in situ run-on assay to label de novo 
transcripts following 4 h treatment with KS (10 11M). Decreased content of nascent RNA 
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was observed in neuronal nucleoli in response to ATM inhibition (Fig. 11 D). The 
decreased ratio between nucleolar- and total nuclear nascent RNA levels suggests the 
anti-transcriptional effects ofK5 were relatively greater in the nucleolus (Fig. lIE). In 
concert with prior observations that A TM is concentrated in the nucleoli of human 
neurons (Gorodetsky et aI., 2007), ATM immunofluorescence co-localized with the 
nucleolar sites of nascent RNA accumulation (Fig. IIF). Finally, lower pre-rRNA levels 
were also observed in the cerebella of 5 week old ATM-1- mice (Fig. 11 G). Together, 
these findings indicate that ATM regulates Poll, not only upon challenge with DNA 
double strand breaks, but also under basal conditions. Such effects may be related to 
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Figure 11: ATM regulates neuronal Poll under basal conditions 
A, Cortical neurons were treated with K5 as well as inhibitors of several well established 
signaling pathways that control neuronal growth and mediate effects of growth factors on 
ribosomal biogenesis, including ERKl /2, (U0126 at 50 flM) ; AKT (LY294002 at 30 
flM) ; mTOR, (KU 0063794, (K006) at 0.3 flM)) , and K5 (10 flM). Their effects on 
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phosphorylation ofERK1I2, AKT, and RPS6 were revealed by Western blotting (p-
T183NI85, ERK1I2; p-S473, AKT; p-S235/236, RPS6). While K5 did not affect 
ERK1I2 activity, it did reduce phosphorylations of AKT and RPS6 phosphorylation 
suggesting that at least in developing neurons ATM plays a role in growth factor 
signaling. B, Cortical neurons were treated with inhibitors as in A. All drugs lowered 
pre-rRNA levels. Averages of 3 independent experiments are shown. C, P7 rat pups (3 
animals/condition) received injections ofK5 (10 nmoles) into the right lateral ventricle; 
after 4 h, pre-rRNA levels in the ipsilateral cortex declined. D-E, Decreased nascent 
RNA levels in neuronal nuclei after K5 treatment. (D) Cortical neurons were treated with 
K5 (lO/-lM) or vehicle followed by incubation with the RNA precursor 5-ethynyluridine 
(5-EU, 1 mM) for 1 h. After fixation and co-immunofluorescence for the nucleolar 
marker B23, nascent RNA was visualized using "click" chemistry. (E) K5 decreased the 
ratio between nucleolar- and nuclear nascent RNA levels. Data are averages of at least 
40 randomly selected individual neurons/condition from 3 independent experiments. F, 
ATM co localizes with 5-EU in the nucleolus. G, Decreased pre-rRNA levels in the 
cerebellum of 5-week old ATM-1- mice. H, Representative mouse IgG control 
immunostaining showing only Hoescht-33258 (blue). In all graphs the averages of3 
independent experiments are shown, error bars indicate SEM; *, p<0.05; **, p<O.Ol; ***, 
p<O.OOl. 
ATM's contributions to the activation of neuronal Poll by BDNF and increased 
synaptic activity 
BDNF provides an extracellular signal that stimulates neuronal growth by 
increasing Poll activity (Gomes et aI., 2011). Therefore, we wondered whether ATM 
played a role in BDNF-mediated activation of Poll. In cultured cortical neurons treated 
with 10 ng/ml BDNF for 4 h, the activation of growth promoting signaling pathways 
including ERK1I2, AKT and mTORcl was indicated by increased phosphorylation levels 
ofT183N185, S473 and S235/236, respectively. Activation ofERK1I2 was unaffected 
by K5. Conversely, K5 prevented AKT activation and reduced mTORcl activity towards 
RPS6. However, K5 interference with mTORcl activation was weaker than that of the 
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PI3K inhibitor, L Y, or the mTOR inhibitor, KU006 (Fig. 12A). These results suggest a 
contribution by ATM to the growth promoting signaling network activated by BDNF. 
To determine effects ofK5 on BDNF-induced activation of Poll , two BDNF 
stimulation conditions were tested. These paradigms included 2 h BDNF treatment in 
full growth medium or 2 h BDNF treatment in trophic deprivation medium, which was 
added to cells 2 h before the BDNF addition. The latter paradigm was used to clearly 
separate K5 effects on the BDNF response from those of trophic factors that are present 
in full growth medium. Indeed, such factors may employ ATM to stimulate Poll as K5 
lowered pre-rRNA levels in full media, but not in trophic deprived neurons (Fig. 12B, C). 
However, BDNF induced nucleolar transcription under both stimulation conditions, while 
K5 reduced the BDNF responses (Fig 12B, C). Similar reductions were also observed 
under inhibition ofPI3K and mTOR. Finally, K5 reduced elevated accumulation of 
nascent RNA in the nucleoli ofBDNF-stimulated neurons (Fig. 12D). Taken together, 
these data suggest that in addition to those PI3K family members that are well established 
regulators of neuronal growth, A TM is critical for the activation of Poll in a growth-
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Figure 12: Activation of Poll in BDNF-stiroulated neurons is dependent on ATM, 
PI3K and roTOR. 
A , Treatment of cortical neurons with BDNF (1 OnglmL) for 4 h increased 
phosphorylations ofERK1I2 (T1831Y185), AKT (S473) and RPS6 (S235/236) 
suggesting activation ofERK1I2, PI3K1AKT and PI3K1mTORc1 , respectively. ERKI /2 
activation was not attenuated by inhibiting ATM (K5), PI3K (LY) or mTOR (K006). 
However each of these inhibitors reduced AKT- and mTORcl activation. Although K5 
prevented AKT activation, its inhibitory effects on BDNF-mediated activation of 
mTORcl were smaller as compared to LY or KU006. B-C, BDNF activation of Poll 
was ATM-dependent. Cortical neurons were treated with BDNF for 2 h as indicated. 
Inhibition of ATM, PI3K or mTOR prevented BDNF-induced increases ofpre-rRNA 
levels. Data are from three independent experiments. D , Co-treatment ofBDNF and K5 
decreased nascent RNA levels in neuronal nuclei. Cortical neurons were treated with 
vehicle or with BDNF in the presence and absence of K5 (10 )lM) followed by incubation 
with the RNA precursor 5-ethynyluridine (5-EU, 1 mM) for 1 hr, as in Figure 11. 
Quantifications are averages of at least 40 randomly selected individual 
neurons/condition from 3 independent experiments. In all graphs, error bars indicate 
SEM; *, p<0.05; **, p<O.O I ; ***, p<O.OOl. 
As synaptic activity also stimulates neuronal growth, we examined whether it 
regulates Poll through the ATM pathway. To stimulate synaptic activity, cultured 
cortical neurons were treated for 4 h with SR95531 (Gabazine), a y-aminobutyric acidA 
(GABAA) receptor antagonist, and 4-aminopyridine, a selective potassium channel 
blocker (Kvl). Confirming prior reports that such treatment stimulates synaptic activity 
and increases ERK1I2 signaling (Ghosh and Greenberg, 1995; Krapivinsky et ai., 2003), 
we observed increased phosphorylation ofERK1I2 that was unaffected by K5 (Fig. 13A). 
Therefore, K5 did not interfere with the neuroexcitatory effects of Gabazine/4AP. 
However, it did block the Gabazine/4AP-mediated induction of Poll (Fig. 13B). This 
inhibitory effect was similar to that of the ERK1I2 pathway inhibitor, U0126, and the 
electrical activity inhibitor, tetrodotoxin (TTX), and the NMDA receptor antagonist, 
MK801. These data suggest that enhanced synaptic activity stimulates Poll-driven 
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transcription in an ATM-dependent manner. Hence, ATM is a critical transducer for the 
growth-associated activation of nucleolar transcription in response to such growth 
promoting stimuli as BDNF and synaptic activity. 
Figure 13 
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Figure 13: Enhanced synaptic activity potentiates neuronal nucleolar transcription 
via ERK1I2 and ATM. 
A , DIV 8 cortical neurons were treated with the GABAA receptor antagonist, Gabazine 
(Gaba) and voltage-gated potassium channel blocker, 4-aminopyridine (4-AP) for 4 h. 
This treatment activated ERK1I2. B, Enhanced synaptic activity drove neuronal 
nucleolar transcription through an ERK1I2 and ATM dependent pathway. DIV 8 cortical 
neurons were treated with inhibitors as indicated. 20 minutes later they were treated with 
Gaba and 4-AP or vehicle for 4 h. As anticipated, the sodium channel blocker, 
tetrodotoxin (TTX), and MK80 I attenuated the neuronal nucleolar transcription induction 
following Gaba/4-AP treatment. Similarly, ERK1I2 inhibition and A TM inhibition in the 
presence of Gaba/4-AP also attenuated the transcriptional induction. In all graphs the 
averages of3 independent experiments are shown, error bars indicate SEM; *, p<0.05; 
**, p<O.Ol ; ***, p<O.OOl. 
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Inhibition of ATM reduces neuronal growth 
To test whether ATM is required for neuronal growth we transfected cortical 
neurons with an expression vector for RFP to label cell bodies and neurites of a few cells 
(14A). After 24 h, pharmacological inhibitors of ATM or mTOR were added for the next 
24 h. To exclude possible interference of negative survival effects of such inhibitors with 
their potential anti-growth actions, a fraction of the transfected (i.e. RFP-positive) cells 
with "healthy," non-condensed morphology of nuclear chromatin were determined 
following nuclear counterstaining with Hoechst33258. None of the inhibitors 
significantly affected neuronal survival (Fig. l4B) . Conversely, total neurite length 
decreased in both ATM- and mTOR-inhibited neurons (Fig. 14C). Although the neuritic 
branching was unchanged, as was the number of primary dendrites (Fig. l4D-E), the 
Sholl analysis indicated decreased neurite complexity following ATM or mTOR 
inhibition (Fig. 14F). In neurons that were stimulated with BDNF, the growth response 
to this neurotrophin was also sensitive to ATM or mTOR inhibitor (Fig. 15). Under 
BDNF-stimulated conditions, the K5 inhibitor did not affect neuronal survival (Fig. 15B). 
However, it significantly attenuated BDNF-mediated increases in dendrite total length 
and the number of primary dendrites (Fig. 15C). In addition, BDNF-mediated increases 
in dendritic length, branching and overall complexity were attenuated by A TM inhibition 
as revealed by the Scholl analysis (Fig 15F). Collectively, these results suggest that in 
addition to mTOR, ATM is a major regulator of neuronal growth. Such a notion is 
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Figure 14: Pharmacological inhibitor of A TM reduced neurite length and neurite 
complexity under basal conditions. 
Cortical neurons were transfected on DIV 3 with an RFP expression vector (0.25 ~g 
plasmid DNAl5 X 105 cells) . Treatments with a vehicle (Veh, 0.2%DMSO), 10 ~M K5 
or 0.3 ~M K006 were initiated on DIV4 and continued for 24 h. A, Representative 
photomicrographs of individual transfected neurons following the inhibitor treatment. B-
F , Morphometric analysis of ATM- or mTOR-inhibited neurons. ATM or mTOR 
inhibition for 24 h had no significant effects on cell survival as determined by the fraction 
ofRFP-positive neurons with a "healthy," non-condensed chromatin that was visualized 
by counterstaining with Hoechst33258. Both inhibitors reduced total neurite length (C) 
without affecting neuritic branching (D) or the number of primary dendrites (E). 
However, Scholl analysis indicated reduced neuritic complexity following treatment with 
either inhibitor. The effect of the A TM inhibitor was mainly on the distal neurites while 
the mTOR inhibitor affected more proximal processes (F) . (B-F), data are from a 
minimum of 36 cells per condition that were analyzed in three independent experiments, 
error bars indicate SEM; *, p<0.05; **, p<O.Ol ; ***, p<O.OOl. 
69 
Figure 15 
A BDNF BDNF" KS 
B C 0 BDNF E 
BDNF BDNF rr BDNF lSoo m 10 m 0.8 co ~ 1200 '" 0 '" .Sl ~ - E ~ .~ ·c 0.6 -; 2; 900 :> .- ::> ., S co OJ.s:: ~ ~ O.S c > 0.4 "' - 600 ~ .~ ~ OJ -5~ ., c co 
::> 0.2 
> ., c co E 
'" co- 300 ~ .§ ·c c-
o 0 c-o II> .,., 0 II> 0 ~ 0 0 ~ 0 0 ~ 0 0 II> ~ 




'" g>6 . Veh ·iii 
'" . BDNF e4 
<.) _ BDNF+KS 
2 
0 
10 100 150 
Radius (flm) 
Figure 15: Pharmacological inhibitor of ATM reduced neurite length and neurite 
complexity in response to BDNF-stimulated growth 
Cortical neurons were transfected on DIY 3 with an RFP expression vector (0.25 I1g 
plasmid DNA/5 X 105 cells). Treatments with vehicle (Veh, 0.2% DMSO), BDNF (20 
ng/mL), and BDNF plus inhibitor: 10 11M K5 treated on DIV4 and continued for 24 h. A , 
Representative photomicrographs of individual transfected neurons following the 
indicated pharmacological treatment. B-F, Morphometric analysis of BDNF-stimulated 
ATM- or mTOR-inhibited neurons. (B) ATM inhibition in the presence ofBDNF for 24 
h had no significant effects on cell survival as determined by the fraction ofRFP-positive 
neurons with a "healthy," non-condensed chromatin that was visualized by 
counterstaining with Hoechst33258. ATM inhibition reduced total dendritic length (C), 
did not significantly affect neuritic branching (D), but did attenuate the number of 
primary dendrites (E). Scholl analysis indicated reduced neuritic complexity following 
K5 treatment (F) . In B-F, data are from a mean of 36 cells per condition that were 
analyzed in three independent experiments, error bars indicate SEM; *, p<0.05; **, 
p<O.Ol ; ***, p<O.OOl. 
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ATM-mediated regulation of Poll in dividing cells 
To test the possibility that ATM regulates Poll activity in proliferating cells, we 
perfonned serum stimulations of the human neuroblastoma SH-SY5Y cell line and 
human cervical cancer HeLa cell line with or without the ATM inhibitor. Under such 
conditions, serum mediated induction ofpre-rRNA expression was abolished in SH-
SY5Y cells (Fig. 16A). In HeLa cells K5 reduced the serum-mediated increase in pre-
rRNA levels by 59% (Fig. 16C). These observations suggest that ATM is required for 
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Figure 16: Requirement of ATM for serum-mediated activation of Poll in dividing 
human cell lines. 
A-C, After overnight serum deprivation of human SH-SY5Y neuroblastoma cells (SH-
5Y) or HeLa cervical cancer cells (HeLa), restoration of the full growth medium that 
contained 10% FBS activated Poll as suggested by increased pre-rRNA levels at 4 h after 
starting such stimulation. Poll activation was reduced in the presence of the ATM 
inhibitor K5 (10 11M). (A) The average of3 independent experiments are shown. (B) 
Data from a representative experiment; (C) the mean percent of the serum-mediated 
increase in pre-rRNA levels from 4 independent HeLa cell experiments is depicted. In all 
graphs, error bars indicate SEM; **, p<O.Ol; ***, p<O.OOl. 
72 
Discussion 
We report that Poll-driven transcription, the rate-limiting step of ribosomal 
biogenesis, is regulated by A TM in both postmitotic neurons and in dividing cells. In 
primary neurons exposed to low level DNA damage, BDNF or enhanced synaptic 
activity, ATM was necessary for increases in Poll activity. In human cell lines of tumor 
origin, ATM was essential for Poll activation by serum. In addition, A TM inhibition 
reduced BDNF-stimulated neurite outgrowth. Collectively, ATM appears to be a major 
regulator of neuronal growth with at least one of its growth promoting mechanisms being 
stimulation of nucleolar transcription. 
The effects of ATM inhibition on ribosomal biogenesis and neuronal growth are 
similar to those affected by interference with the ERK1I2- or the mTOR signaling 
pathways. In cultured neurons, ATM inhibition reduced activity of the PI3K1AKT and 
the PI3K1mTOR pathways without affecting ERK1I2. As PI3K1mTOR signaling 
regulates Poll and is essential for neuronal growth, pro-ribosomal and pro-growth effects 
of ATM may be due to its role in activation ofmTOR. Indeed, ATM has been implicated 
as a growth factor-stimulated kinase for AKT on residue S473 which by activating AKT 
could regulate mTOR. Alternatively, being somewhat similar to mTOR, ATM could 
offer a parallel pathway that would be activated by similar upstream mechanisms and 
target similar downstream substrates. In support of these notions, the principal activator 
ofmTOR, Rheb, can also interact with ATM (Long et aI., 2005). Similarly, 4E-BP has 
been shown as a common substrate for both kinases (Yang and Kastan, 2000; Hannan et 
aI.,2003). In neurons ATM is found in the cytoplasm, at the membrane, in neurites and 
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in the nucleolus. As such, it may interact with both mTOR activators and a wide 
spectrum of critical pro-growth substrates of that pathway. Finally, the ATM localization 
to the nucleolus may offer a unique position to regulate ribosomal production. While at 
least two nucleolar regulators of that process including nucleophosmin and nucleolin 
have been shown to be direct substrates of ATM (Nalabothula et aI., 2010), the impact of 
their ATM-mediated phosphorylations on Poll activity remains to be determined. 
We previously identified Poll as a major neuronal growth effector for the BDNF-
activated ERK1I2 pathway (Gomes et aI., 2011). Therefore, it is tempting to speculate 
that Poll may be equally important for the neuronal growth regulation by other growth 
promoting pathways such as mTOR or ATM. Conversely, there may be additional 
mechanisms by which these kinases promote neuronal growth. Such mechanisms may 
include regulation of neuronal cytoskeleton and stimulation of local protein synthesis. 
Relative contributions of ribosomal biogenesis, translational regulation and cytoskeletal 
dynamics to the A TM effects on neuronal growth are to be determined. 
Autophosphorylation of ATM on S 1981 is a well-established indicator of its 
activation by DNA damage or oxidative stress (Bakkenist and Kastan, 2003; So et aI., 
2009; Guo et aI., 2010a). It was also observed during retinoic acid- (RA) induced 
differentiation ofSH-SY5Y neuroblastoma cells (Fernandes et aI., 2007). However, no 
evidence for S 1981 autophosphorylation has been presented in a paradigm of insulin-
mediated activation of ATM (Yang and Kastan, 2000). Similarly, while neuronal ATM 
was strongly autophosphorylated in response to Top02 inhibition, no change in pS 1981 
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levels could be detected after BDNF stimulation or enhancement of synaptic activity 
(data not shown). Therefore, growth-promoting signals may activate ATM via 
alternative mechanisms that do not involve its autophosphorylation at S 1981. Our future 
studies will address these mechanisms, including the possibility that neurotrophic factor-
activated small GTPases, such as Rheb, activate ATM in the absence of DNA damage. 
There is growing evidence that reduced ribosomal biogenesis contributes to 
neurodegeneration. For instance, inducible disruption of Poll activity by knocking out its 
co-activator TIF -1 A in mature mouse neurons resulted in degeneration of various 
neuronal populations including cortical and hippocampal neurons, striatal neurons and 
substantia nigra neurons. In the latter system, Poll inhibition also led to oxidative stress. 
Partial insufficiency of neuronal nucleolar transcription has been demonstrated in 
Alzheimer's disease and associated with increased oxidation of rRNA and ribosomal 
failure (Ding et aI., 2005). Such effects were also observed at the early stages of AD 
(Ding et aI., 2006). Interestingly, iron-catalyzed Fenton reactions have been proposed as 
a primary source ofrRNA damage in AD brains (Honda et aI., 2005). In addition, 
degeneration of striatal neurons in Huntington's disease has been associated with HD-
linked mutations in hunting tin that directly block the Poll-specific transcriptional 
regulator, UBF (Lee et aI., 2011). Therefore, it is tempting to speculate that A-T-
associated neurodegeneration, which is accompanied by oxidative stress and attenuated 
by iron complexing, may be at least in part due to insufficient ribosomal biogenesis. 
Such insufficiency could slow the rate of replacement of damaged ribosomes, reduce 
protein synthesis capacity, and trigger neuronal atrophy and degeneration. Our future 
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studies will evaluate whether nucleolar impainnent contributes to neurodegeneration in 
A-T. 
In addition to neurodegeneration, A-T patients suffer immune deficits, and 
demonstrate retarded growth and accelerated aging. At least some of these defects were 
associated with reduced proliferation of ATM-deficient cells. We found that in addition 
to neurons, ATM regulated Poll-mediated transcription in proliferating cells. 
Intriguingly, Poll activity is a critical regulator of cell growth and division (Drygin et aI., 
2010). In fact, Poll is the major effector for such principle cell cycle driver as c-Myc. 
Unsurprisingly, in most cases of oncogenic transfonnation, Poll activity is deregulated 
by loss of function mutations in tumor suppressor genes, or gain of function mutations in 
oncogenes (Drygin et aI., 2010). Interestingly, reduced proliferation and premature 
senescence in ATM-null mouse fibroblasts is rescued by inhibiting the nucleolar sensor 
protein and a negative regulator of ribosomal biogenesis, pl9ARF (Kamijo et aI., 1999). 
Thus, it is likely that insufficient ribosomal biogenesis may account for the growth 
defects of A-T cells, thereby contributing to at least some non-neurological symptoms of 
that disease. Finally, blocking A TM may offer yet another strategy to block tumor 
growth by interfering with ribosomal biogenesis. 
Collectively, we demonstrate a new role of ATM in the regulation of ribosomal 
biogenesis and neuronal growth. While such activity goes beyond its well-established 
role in the DNA damage response, this function fits well with its similarities to the 
growth-promoting members of the PI3K family, including PI3K and mTOR. Therefore, 
one may consider that functional specialization of the members of this family is not 
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absolute. Rather, functional redundancies and/or mutual regulatory connections between 
PI3K family members contribute to the integration of information about genome 
integrity, nutrient availability and growth factor exposure. 
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Restatement of the key findings 
These studies concentrated on describing the regulation of Poll-mediated 
transcription in neurons. In Chapter II, I reported that etoposide treatment suppressed 
Poll transcription and disrupted nucleolar integrity in cortical and hippocampal neurons 
of whole rats irrespective of developmental stage. However, in the developing, but not 
the mature brain, etoposide induced apoptosis. Additionally, other experiments 
performed in the Hetman laboratory in connection with these studies have demonstrated 
that in etoposide-treated neurons SSBs and/or protein DNA adducts provided the main 
interference with Poll, while DSBs were the main trigger for apoptosis (Pietrzak et ai., 
20 II b). Taken together these findings suggest that the nucleolus may playa role of a 
genomic integrity sensor in both young and adult neurons. In addition, they suggest that 
the aging- or neurodegeneration-associated accumulation of SSBs or large DNA adducts 
may disrupt ribosomal biogenesis thus compromising protein synthesis and leading to 
neuronal atrophy. 
In Chapter III, I report the identification of A TM as a novel regulator of Poll-
mediated transcription in postmitotic neurons and in proliferating cell lines. These 
findings suggest that reduced production of ribosomes may contribute to the A-T-
associated neurodegeneration and impairment of cellular proliferation. Therefore, in 
addition to being a DNA repair disorder, A-T may also be a ribosomal disease. 
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Collectively, these findings suggest that Poll-mediated transcription is a target for the 
neurodegeneration associated forms of DNA damage including SSB and DNA adducts 
and the neurodegeneration-inducing deficiencies in ATM signaling. 
Limitations and alternative interpretations 
In Chapter II, etoposide was injected directly into the lateral ventricle of neonate 
rats, while in the adult rats the delivery was via the intracarotid artery. These different 
methods of delivery required different doses (Maeda et aI., 1999). Though I witnessed 
comparable effects on the activity of nucleolar transcription and nucleolar disruption in 
both treatments, one may question whether these two methods are comparable. 
Etoposide delivery via the intracarotid artery following blood brain barrier disruption has 
been used in the clinic (Madajewicz et aI., 1991), but this method may affect other 
systems upon delivery. The toxicity evaluations of humans treated with etoposide via the 
intracarotid artery indicated only neurological effects on few patients and hematomas at 
injection sites (Madajewicz et aI., 1991). In adult rats treated through the intracarotid 
artery, etoposide caused hypo activity and slowed breathing 5 h after treatment. 
Conversely, neonate rats treated with etoposide directly to the lateral ventricle were 
nursing within 1 h after treatment and survived up to 72 h after treatment. Unfortunately, 
adult rat longevity post-treatment was not evaluated beyond 6 h. However, a decreased 
dose of 5 mglkg delivered via the intracarotid artery allowed survival up to 72 h. 
Hypoactivity and slowed respiration was witnessed under this treatment condition for up 
to 2 h after treatment, however nucleolar disruption was not noted microscopically in 
either of 2 animals treated with this dose. These findings are consistent with the lack of 
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biological effect observed by other researchers with a dose of 3 mg/kg delivered through 
the intracarotid artery (Maeda et ai., 1999). Conversely, the dose delivered to the 
neonates caused neuronal nucleolar stress and apoptosis. Data from etoposide treatment 
in vitro may offer an explanation as to the lack of nucleolar effect after 5 mg/kg of 
etoposide treatment in vivo. Doses of etoposide treatment below 25 11M were unable to 
cause nucleolar transcription in cultured neonate cortical neurons. Instead, treatments 
below this concentration caused apoptosis, while the higher doses of etoposide, which 
induced more SSBs and DNA-Top02 adducts caused nucleolar stress (Pietrzak et ai., 
2011 b). Upon intracarotid delivery some drug is likely taken up by the arterial 
endothelium, and is relatively diffused by its path throughout the ipsilateral hemisphere, 
while delivery to the ventricle concentrates the treatment to a relatively smaller area. 
Further, the osmotic disruption of the blood brain barrier increases drug delivery 
efficiency, but remains less efficient for drug delivery than ICV delivery. These elements 
likely support the in vivo absence of nucleolar stress following 5 mg/kg doses of 
etoposide in the adult. As the biological effect on the nucleolus was comparable between 
intracarotid delivery of 15 mg/kg and ICV neonate delivery of 10 nmoles, in terms of 
Poll suppression and observed cell frequency (i.e., all cells), the doses are likely 
comparable despite different systems of delivery. 
NPM/B23 translocation to the nucleoplasm occurred in all analyzed cells 
following 15 mg/kg of etoposide delivery to the adult rat brain, yet apoptosis was absent, 
which may suggest a neuronal protective threshold, rather than absence of biological 
effect. Instead, the absence of apoptosis is a function of neuronal maturation. Adult 
neurogenesis cannot replace all neurons in the brain, thus longevity of adult neurons is 
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required. Therefore, with increasing age, neuronal protection from apoptosis gradually 
becomes the default setting, whereas prior to maturity apoptosis was the default setting. 
Embryonic day 15-16 mouse cortical neurons maintained in culture for 25 days have a 
reduced apoptotic response following etoposide treatment than do like-treated neurons 
cultured for 5 days. This effect is partially associated with the reduction of p53-
responsiveness in 25-day cultured neurons compared to 5-day cultured neurons (Martin et 
aI., 2009), and the nearly complete reduction of 5-day cultured apoptosis in p53-1- neurons 
compared to the remaining apoptotic response in 25-day cultured p53-1- neurons. These 
results suggest that p53-mediated apoptosis in response to DNA damage decreases with 
increasing neuronal age (Martin et aI., 2009). Further, the tyrosine kinase c-Abl, binds 
p53 in response to DNA damage and suppresses apoptosis in mature neurons and its 
deletion is protective in immature neurons (Martin et aI., 2009). 
The increased threshold to apoptosis is at least partially attributed to the reduction 
of pro-apoptotic molecules with increasing age, however increased expression of anti-
apoptotic molecules can also increase the cellular threshold to apoptosis in mature 
neurons (Benn and Woolf, 2004). For instance, such anti-apoptotic mediators are likely 
responsible for the neuronal maturation-related delay in the release of cytochrome C 
which is a critical step in apoptosis (Wright et aI., 2007). Apafl binds cytochrome C in 
the cytosol, and together they form the apoptosome. Apafl expression is suppressed in 
mature neurons, thus altering the recruitment of caspases to the apoptosome. Mature 
neurons grown in culture are sensitive to etoposide treatment, but at a slower rate than 
immature neurons and that change in sensitivity is Apafl-dependent (Wright et aI., 2007; 
Vaughn and Deshmukh, 2008). Moreover, endogenous expression of Apafl in mature 
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neurons is re-established following DNA damage, and dependent upon the availability of 
chromatin to the transcriptional machinery (Wright et aI., 2007; Vaughn and Deshmukh, 
2008). It is possible that the increased threshold to apoptosis protected the somas of the 
etoposide-treated adult cortical neurons, and that the toxicity was targeted to the neurites, 
resulting in the degeneration of the neural processes. Indeed, such notions have been 
described earlier following transient ischemia (Fukuda et aI., 1999), endogenous toxicity 
in a an amyothrophic lateral sclerosis model (Gould et aI., 2006) and a DNA damage 
repair mutant (de Waard et aI., 2010). If true, it is possible that such effects may have 
been missed upon morphological evaluation. On the other hand, cleaved caspase-3 
staining markedly identified the cytoplasm of cells undergoing apoptosis (Figs. 6, 7). It 
is also conceivable that ultrastructural changes were subtle at the 6 h time point for adult 
neuron apoptosis. Similarly, only 6 h may have been insufficient time to see mature 
neuron death. Indeed, 2S-day cultured neurons acquired fewer DSBs, as determined by 
comet assay, compared to S-day cultured neurons after 4 h of etoposide treatment (Martin 
et aI., 2009). Further, the susceptibility to DNA damage-mediated apoptosis in mature 
neurons is slowed compared to immature neurons, thereby supporting such a notion 
(Wright et aI., 2007). 
In Chapter III, I used the pharmacological agent KUSS933 (KS) as an inhibitor of ATM 
in order to establish ATM's role in ribosomal biogenesis. The selectivity and 
functionality of this inhibitor to ATM has been well-established as a competitive ATM 
binder (Hickson et aI., 2004; Bryant and Helleday, 2006; Li and Yang, 2010). The 
reliance we have placed on KS as an inhibitor of ATM is potentially problematic, but was 
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necessary because multiple attempts to knock down ATM using short hairpin RNA 
(shRNA) were unsuccessful. KS activity in our cellular system has been identified by the 
inhibition of ATM autophosphorylation at S 1981 in response to etoposide treatment, as 
indicated by Western blot analysis. The autophosphorylation site S 1981 is not 
phosphorylated in response to non-DNA damage-related stimuli such as Gabazine or 
BDNF (data not shown). Therefore, ATM inhibition by KS in response to these 
stimulations was not identifiable by Western blot, nor was KS inhibition of A TM under 
basal conditions. Further, despite published KS specificity to inhibit ATM in cycling 
cells, its use in neurons has not been previously reported. As such, KS's specificity to 
ATM in our neuronal system has only been assumed. It is therefore possible that KS may 
be metabolized in our cellular system in a manner that reduces its specificity to ATM, 
thus suggesting that the KS effects on nucleolar transcription could be partly mediated 
through signaling pathways that engage relatives of ATM, such as PI3K or mTOR. Both 
the PI3K and mTor are known to respond to neurotrophins and neuronal activity. 
However, in etoposide-treated neurons, I observed a KS-sensitive induction of rDNA 
transcription in the absence of any evidence for PI3K1mTor activation. Furthermore, the 
inhibition of mTOR by K006 for 24 h did not have the same effect on neurite outgrowth 
as did KS treatment for 24 h. Most importantly, Poll-driven transcriptional impairment 
was identified in the cerebellum of ATM-null mutant mice. This finding provided 
genetic loss of function data that paralleled Poll-mediated transcriptional responses in 
KS-treated neuronal cultures and ICV infusion of KS in the rat neonate neocortex. 
Therefore, it is unlikely that KS treatment provided major inhibitory effects on Poll 
transcription by a means other than inhibiting A TM in our systems. 
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Our work has provided evidence that supports the involvement of ATM in 
nucleolar transcription as a far-reaching biological phenomenon. First, the recapitulation 
of nucleolar transcription suppression following K5-mediated ATM inhibition in vivo 
provides evidence that Poll-mediated transcription in multiple cell types is incomplete 
without ATM involvement. As glia make up a significant portion of the neonate brain, 
this result suggests that ATM's involvement in nucleolar transcription may not limited to 
neurons. Broad biological involvement of A TM in nucleolar transcription is further 
evidenced by the work conducted in the HeLa and SHSY-5Y immortalized human cell 
lines. The potentiation of Poll-mediated transcription in response to serum 
replenishment after serum starvation is attenuated by K5-mediated inhibition of ATM. 
The absence of A TM does not cause a complete inhibition of nucleolar transcription, but 
rather a reduction compared to basal levels, presumably via redundancy by other 
pathways that regulate Poll. ATM deficiency in the cerebellum of 5-week-old ATM-null 
mice shows evidence of Poll-mediated transcriptional suppression, while II-week-old 
mutant mice show enhanced Poll-mediated transcriptional inhibition (data not shown). 
At II-weeks of age the cerebellar Purkinje cells have started to degenerate in the ATM-
null mutant mouse lines (Li et aI., 2011). Neurodegeneration is known to stimulate 
reactive gliosis (Smith et aI., 20 II). As such, we hypothesized that the increased 45S 
rRNA levels were due to reactive glia responding to the neurodegeneration, and therefore 
evaluated the levels of glial fibrillary acidic protein (GF AP) at both the 5-week and 11-
week ages. These results showed that GFAP levels were no different in 5-week ATM-
null mice compared to wildtype, but were significantly increased in the II-week old mice 
compared to wildtype (data not shown). This may suggest that in the absence of ATM, 
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reactive glia were able to increase nucleolar transcriptional presumably using other 
pathways such as mTor or ERK1I2. Importantly, it does not suggest that the ATM-
mediated suppression of Poll is rescued by reactive gliosis, but rather that the increased 
growth of dividing cells masks the net effect on Poll. 
Activation of A TM is identified by its autophosphorylation at S 1981, the 
canonical DNA damage-mediated activation site (Bakkenist and Kastan, 2004). Attempts 
to show A TM autophosphorylation at S 1981 following BDNF or synaptic activity 
stimulation have been unsuccessful. Though critics may interpret such a finding as 
evidence for ATM unresponsiveness to trophic stimuli, an alternative interpretation that 
considers other supporting data is that non-DNA damage-related stimuli activate ATM 
without affecting auto activity at S 1981. Indeed, ATM has been shown to have multiple 
autophosphorylation sites (Kozlov et aI., 2006; Kozlov et aI., 2011). Moreover, evidence 
of ATM activation in response to oxidative stress has been shown to be separate from its 
activation in response to double-stranded breaks. Indeed, the A TM dimer is activated by 
redox reaction in response to oxidative stress instead of by phosphorylation of an ATM 
monomer (Guo et aI., 201Oa; Guo et aI., 201Ob). 
Due to the involvement of nucleolar transcription in neurite outgrowth (Gomes et 
aI., 2011), we assessed the effect of24 h pharmacological inhibition of ATM on neurite 
outgrowth in developing neurons in culture compared to vehicle and mTOR inhibition 
treatments. Both mTOR and ATM inhibition suppressed neurite outgrowth under basal 
conditions. ATM inhibition under BDNF-stimulated conditions also robustly suppressed 
neurite outgrowth. These results suggest a downstream biological effect on neurites 
following sustained nucleolar transcriptional suppression, and support the notion that 
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ATM is a growth-promoting kinase (Yang and Kastan, 2000; Li and Yang, 2010). 
However, as ATM has been shown to be involved in insulin signaling and translation 
initiation (Yang and Kastan, 2000; Li and Yang, 2010), and mTOR is a well-established 
upstream mediator of protein synthesis and cellular growth (Mayer et aI., 2004; Ruvinsky 
and Meyuhas, 2006; Swiech et aI., 2008), the ant-growth effects ofKS and K006 may 
also involve these additional effectors besides Poll. For instance, 24 h pharmacological 
inhibition of ATM and/or mTor may have reduced phosphorylation of 4E-BPI, and thus 
decrease translation (Mayer et aI., 2004; Ruvinsky and Meyuhas, 2006). Further, it is 
possible that the effects we have witnessed in neurite morphogenesis are the outcome of 
changes in cytoskeletal dynamics in response to ATM inhibition mediated through an 
interaction with nuclear factor kappa B (NF-KB) (Gutierrez and Davies, 2011; Semlitsch 
et aI., 2011). 
Result artifacts can stem from the system with which we've been working, despite 
having controls in the same system. Harvesting primary cortical neurons requires 
trituration to separate cell clumps. This process is an unnatural one, and thus may cause 
cellular damage. Further, in order to grow an enriched population of cortical neurons, 
glia proliferation must be suppressed. Arabinofuranosyl cytidine (AraC), a genotoxin, is 
used to prevent the growth of dividing glia cells in our culture system. Though AraC has 
been widely used, including in the Hetman lab, and it does not appear to have negative 
effects on neurons at the concentrations used, it may theoretically activate DNA damage 
response contributing to the apparent ATM signaling in response to non-genotoxic 
stimuli. Perhaps the greatest source of artifact, because of A TM's ability to respond to 
oxidative stress, is the non-physiological oxygen/C02 conditions of the incubators in 
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which the neuronal cultures were maintained. The 95% air/5% CO2 content may 
generate oxygen radicals that activate ATM in a manner that will not induce its 
autophosphorylation at S1981, but nonetheless induce ATM activity (Guo et aI., 201Oa; 
Guo et aI., 20IOb). These complications imply further importance on the recapitulation 
of the key in vitro results in the whole animal. Supporting these in vitro results, we 
observed suppressed Poll-mediated transcriptional activity in the Atm-I- cerebella, and in 
whole rat neonates after infusion of K5 intracerebroventricularly. 
Etoposide as a novel suppressor of neuronal Poll 
Etoposide inhibits Top02 causing single-stranded breaks in DNA and DNA-Top02 
adducts, as well as double-stranded breaks (Bromberg et aI., 2003; Pietrzak et aI., 2011b). 
Oxidative- or energy deprived-mediated cellular stress-derived impairment of nucleolar 
transcription can be mediated by JNK2 or AMPK, respectively (Mayer et aI., 2005; 
Hoppe et aI., 2009). Genotoxic stress-induced Poll transcriptional inhibition is further 
dependent upon the presence of ATM (Kruhlak et aI., 2007), and may also be a response 
to physical interference caused by DNA lesions (Hetman et aI., 2010). Regardless of the 
mechanistic detail, the transcriptional pause offers an opportunity to conserve energy, 
prevent cell cycle entry and growth, and provides an opportunity to respond and perhaps 
repair genotoxic damage. 
In cycling cells, nucleolar transcription halts and the nucleolus disappears upon 
mitotic entry by the phosphorylation ofTAF111O at T852 by Cdkl-CyclinB (Drygin et 
aI., 2010; Grummt, 2010). This phosphorylation impairs the SLl/TIF-lB interaction with 
UBF to prevent initiation complex formation. This SLl/TIF-lB - UBF interaction is also 
prevented by JNK2 phosphorylation ofTIF-IA at T200 in response to oxidative stress 
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(Mayer et aI., 2005). JNK2 signaling to impair nucleolar transcription may be specific to 
oxidative or bulky adduct lesions as irradiated JNK2 deficient cycling cells continue to 
transcribe rDNA (Kruhlak et aI., 2007). Though DNA damage may cause physical 
impairments on DNA that prevents promoter binding (Marietta et aI., 2002) or 
transcriptional elongation (Hetman et aI., 2010), irradiation-mediated DNA damage may 
cause Poll transcriptional inhibition by the activity of DNA damage repair enzymes such 
as ATM (Kruhlak et aI., 2007). While my data does not support the role of ATM as a 
suppressor of Poll, a possibility that JNK2 or CDKs play such a role in etoposide-
exposed nervous system is worth further testing. 
Etoposide treatment required high concentrations to suppress Poll-mediated 
transcription in cortical neurons cultured from newborn rats, and in neonate and adult 
brains. Though we concentrated our analysis on postmitotic neurons, in vivo 
immunohistochemical staining ofNPMlB23 suggested that all analyzed cellular nucleoli 
were disrupted. This would suggest that at the etoposide concentrations used, the 
nucleoli of glia were equally susceptible to nucleolar disruption as were neurons. In 
contrast, researchers using wildtype MEFs treated with 20 )lM etoposide showed Poll-
mediated transcriptional inhibition (Kruhlak et aI., 2007), while Atm-I- MEFs did not. 
These results suggest that the response to etoposide is akin to the irradiation response, 
even at low concentrations of etoposide (Kruhlak et aI., 2007). Though this may initially 
appear like a discrepancy, it would suggest that dividing cells are more susceptible to 
genotoxic damage than postmitotic cells, such as neurons. The etoposide concentrations 
used in the neonate and adult brain exceeded the threshold for glial transcriptional 
inhibition (perhaps around 20 )lM, or in the brain 2 nmoles), whereas postmitotic cells 
88 
required higher concentrations of the single-stranded breaks and bulky adducts for 
nucleolar disruption. Therefore, it may be no surprise that our observations could not 
identify non-neuronal cells that had completely intact nucleoli. Further, in the neonate, 
10 nmoles of etoposide resulted in an incomplete disruption, as evidenced by diffusion of 
NPMlB23 in the nucleoplasm with some remaining punctuate staining foci ofNPM/B23 
in the nucleolus. 
ATM as a novel positive regulator of Poll 
It may not be surprising that ATM can influence the activity of Poll given its 
downstream influence over the cell cycle in response to double-stranded DNA breaks. 
Indeed, Poll-mediated transcription is ongoing in MEFs lacking ATM, and inATMI-
cells in the presence of irradiation or etoposide treatment, while other DNA damage 
signaling kinases are dispensable (Kruhlak et aI., 2007). These data suggest that ATM 
transiently inhibits the assembly of the Poll initiation complex following DNA damage 
by a yet unknown mechanism, and leads to displacement of elongation enzymes. Within 
one hour, MEFs exposed to irradiation or etoposide recovered from Poll-mediated 
transcriptional arrest. The activation of ATM is likely mediated by the DNA torsional 
strain applied by the induction of bulky adducts by irradiation or etoposide, as ATM is 
autophosphorylated by chromatin rearrangement (Bakkenist and Kastan, 2003; Berkovich 
et aI., 2007; Iijima et aI., 2008). One may hypothesize that this response is mediated by 
JNK2, as the nucleolar stress signaling kinase (Mayer et aI., 2005; Mayer and Grummt, 
2005), but in these conditions the nucleolar stress response requires A TM while JNK2 is 
dispensable (Kruhlak et aI., 2007). The DNA damage-mediated suppression of Poll and 
subsequent nucleolar disruption, which ultimately leads to p53 accumulation, may be an 
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important step to promote a p53-ATM interaction with an active ATM to potentiate a 
stress response signal transduction cascade. 
Data presented herein support the hypothesis that ATM is a regulator of Poll-
mediated transcription, but in a manner outside the realm of DNA damage signaling. 
Kruhlak, et al. suggest that ATM activation impairs Poll transcriptional activity and 
ATM deficiency prevents Poll transcriptional suppression. Conversely, data presented 
here suggest that ATM is a regular contributor to induce Poll-mediated transcription and 
its absence suppresses Poll-mediated transcription when compared to basal levels. 
Though this finding may appear to be a contradiction to the Kruhlak, et al. data, upon 
further evaluation of that report, it is clear that basal levels of Poll transcription were not 
quantified and compared between A TM deficient and control cells. Therefore, it is 
possible that in the ATM deficient MEFs and fibroblasts, Poll-mediated transcription 
was basally impaired compared to control cells. Continuing in that logic, Poll-mediated 
transcription would have remained viable due to canonical Poll regulators, such as 
ERK1I2, PI3K and mTOR. Etoposide likely activated ATM in response to Topo2 pause 
that causes DNA torsional strain (Bakkenist and Kastan, 2003). The low etoposide dose 
(lIlM) and short kinetics (4 h) likely contributed to my ability to detect the induction of 
Poll-mediated transcription. It is possible that ATM was immediately and locally 
activated in response to the DNA torsional strain, which may have loosened chromatin at 
the site of damage either by supercoiling or by recognition of the damage and recruitment 
of responding enzymes, such as the MRN complex. Despite the complexities associated 
with A TM activation following DNA damage, etoposide may cause dichotomous ATM 
behavior depending upon its kinetics and concentration. 
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Despite the majority of our work being conducted in cultured, primary neurons 
obtained from newborn rats, we extended our findings to the neocortex of rat neonates, as 
well as cycling, immortalized human cell lines. Indeed, the basal suppression of Poll-
mediated transcription in response to ATM inhibition is robust enough to be identified in 
RNA extracted from whole brain lysates, of which multiple cell types are present. 
Further, these findings were recapitulated in ATM deficient mouse cerebella, the RNA of 
which was also extracted from whole cerebellar lysates. The findings herein suggest that 
the ATM-mediated contribution to Poll-mediated transcription is ubiquitous. This 
suggestion may even be extrapolated to previous reports of A TM being required for 
etoposide-mediated nucleolar suppression in MEFs (Kruhlak et aI., 2007). Had these 
researchers been evaluating nucleolar transcription following a detailed etoposide dose 
response, they may have also witnessed the finding we report herein. However, the Poll-
mediated suppression response to ATM deficiency can be masked by other signaling 
pathways that contribute to Poll-mediated transcriptional activity. An example of this 
masking can be taken from the glial response to neurodegeneration in ATM-deficient 
mice. Growth is required by glial cells to fill in the tissue gaps created by atrophying 
neurites. The stimulation of Poll-mediated transcription by PI3K1mTOR and/or ERK-
MAPK is sufficient to stimulate growth, but would be less stimulatory to Poll 
transcription than an equally reactive gliosis in ATM wildtype brain that also had 
PI3K1mTOR and/or ERK-MAPK input. The ATM input, therefore, may also be growth-
related, and thus have an upstream activator sufficient to provide such growth-stimulated 
input. 
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Great progress has been accomplished in recent years in identifying the DNA 
damage-mediated activation of ATM. Relaxation of chromatin appears to be the 
activating stimulus of ATM, which is a homodimer prior to autophosphorylation at 
Sl981 (Bakkenist and Kastan, 2003). Despite the presence of numerous DNA damage-
initiated autophosphorylations (Kozlov et aI., 2011), once autophosphorylated at S 1981 
the dimerized A TM dissociates and its monomers are recruited to the sites of damage. 
The dimerized form of A TM is integral for its capacity to signal in response to oxidative 
stress (Guo et aI., 2010b). ATM oxidation causes formation ofa disulfide bond cross-
linker at a specific cysteine (C2991) between the two monomers, yet the responsiveness 
of ATM to DNA damage is unaffected by site-directed mutagenesis ofC2991 (Guo et aI., 
201 Ob). We have observed that S 1981 autophosphorylation is absent in synaptic activity-
, or BDNF-stimulated neurons (data not shown), yet ATM inhibition suppresses the Poll-
mediated transcriptional drive associated with these processes. This suggests that ATM 
could be a dimer in regulating nucleolar transcription. Further support for this possibility 
comes from the basal levels of nucleolar transcription that are impaired upon ATM 
inhibition. What then could be the possible upstream activator of the dimer form of 
ATM? Upstream activation ofPI3K-like family members such as PI3K and mTOR can 
be mediated by small GTPases (Long et aI., 2005; Aspuria et aI., 2007). The amino acid-
mediated activation ofmTOR is thought to be mediated by the small GTPase, Rheb 
(lnoki et aI., 2005; Long et aI., 2005). Rheb is ubiquitously expressed in all tissues, but 
particularly enriched in the brain (lnoki et aI., 2005). Indeed, it is the brain enrichment 
that is its namesake: Ras homolog enriched in brain. The Rheb interaction with mTOR 
has linked it to S6K and 4EBPI activation (lnoki et aI., 2005). Interestingly, this GTPase 
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has been further shown to interact with ATM (lnoki et aI., 2005). Though the function of 
this interaction is not known, such a discovery offers an attractive activation mechanism 
possibility for ATM-regulated nucleolar transcription. As Rheb has already been 
identified in activating mTOR in response to nutrient presence and inducing S6K and 
4EBP1 activation (lnoki et aI., 2005; Long et aI., 2005), it is conceivable that Rheb could 
activate ATM to stimulate nucleolar transcription in response to cellular need. A 
potential problem with this hypothesis is that Rheb is cytoplasmic - activated by the 
GTPase activating protein (GAP), TSC2, whereas ATM is enriched in the nucleolus, near 
its transcriptional target. Though conceivable that Rheb could shuttle to the nucleolus, 
another GTPase, Nog1, resides in the nucleolus and regulates rRNA maturation (Park et 
aI., 2001; Lapik et aI., 2007). Though there is no evidence of interaction with ATM, 
Nog1 complex formation has been shown to be regulated by mTOR and function in the 
nucleolus to mediate late ribosomal maturation (Honma et aI., 2006). These findings 
provide enough circumstantial evidence to warrant further investigation ofNogl or Rheb 
as an upstream activator of ATM-mediated nucleolar transcription. 
The nucleolar ATM target to induce Poll-mediated transcription is currently 
unknown. A search of phosphorylation sites on nucleolar transcriptional machinery 
offers possibilities that include NPMIB23 (Li et aI., 2007; Nalabothula et aI., 2010), and a 
proteomics report of an undescribed interaction between SIRT7 and ATM (Tsai et aI., 
2011), while others have reported irradiation-mediated phosphorylation ofTAF1C, and 
TTF1 by ATM (Matsuoka et aI., 2007). TAF1C is a component ofSLl/TIF-1B, involved 
in regulating the interaction between Poll and the rDNA promoter and required for 
transcriptional elongation (Anney et a!., 2010; Drygin et a!., 2010). The other potential 
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ATM targets (TTFI, NPMlB23 and SIRT7) may be intimately related to the regulation of 
Poll-mediated by ATM. NPMlB23 is a particularly attractive choice as its histone 
chaperone activity has been identified to enhance Poll-mediated transcription by binding 
to the chromatin surrounding the rDNA promoter (Murano et aI., 2008). Further, the 
NPMlB23 SI25 residue has been identified as an ATMlATRJSMG phosphorylation site 
(Maiguel et aI., 2004; Nalabothula et aI., 2010). In addition, the abundance ofNPMlB23 
is directly proportional to the rate of transcription, perhaps to maintain the euchromatin 
structure (Murano et aI., 2008). Evidence suggests that NPMlB23 is upregulated in ATM 
deficient cells (Nalabothula et aI., 2010), the reasons for which are not yet entirely clear 
(Colombo et aI., 2011). A simple explanation for this observation could be that because 
p53 is increased in ATM-deficient cells (Kamijo et aI., 1999), the increased expression of 
NPMlB23 is a response to negatively regulate p53 stabilization (Nalabothula et aI., 
2010). 
Additional ATM targets include TTFI and SIRT7. TTFI is one target potentially 
intimately related to NPM/B23. NPMlB23 is used as a chaperone to shuttle a nucleolar 
localization sequence-bound TTFI from the nUcleoplasm to the nucleolus to initiate 
rDNA transcription. In contrast, ARF prevents TTFI from accumulating in the nucleolus 
by blocking the nucleolar localization sequence, thereby preventing rDNA transcription 
(Lessard et aI., 2010). A recent proteomics study identified an interaction between ATM 
and SIRT7 (Tsai et aI., 2011). This interaction was presented in a supplemental data list 
of proteins that showed positive interaction with SIRT7. However, SIRT7 has been 
shown to interact with UBF and is necessary for sufficient Poll transcriptional activity 
(Ford et aI., 2006; Grob et aI., 2009) by its promotion of chromatin remodeling (Tsai et 
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aI., 2011). Perhaps the chromatin remodeling function of SIRT7 activates ATM, which 
subsequently phosphorylates NPM either to initiate TTFI nucleolar localization, or as 
part of a previously unidentified initiation complex. 
Whatever the upstream activator and nucleolar target is, the nucleolar enrichment 
of ATM may be functionally important. Among its other functions, ATM can be 
included as a growth-stimulating kinase (Yang and Kastan, 2000; Li and Yang, 2010). 
Adding ATM to the other pathways that positively regulate rDNA transcription provides 
further layer of regulation of an extremely important process. What about ATM favored 
its contribution to this redundant activity? During evolution, did the primary functions of 
ATM include Poll regulation as may be indicated by its nucleolar enrichment? Can 
ATM as SMG-l (also known as ATX) respond to damage and or secondary structures in 
RNA and if so, could rRNA processing activate an ATM -dependent auto feedback loop 
that drives Poll? These are all intriguing questions that if answered may provide 
additional information about this novel positive regulator of nucleolar transcription. 
Consequences of nucleolar dysfunction 
Dysfunctional ribosomal biogenesis has an obvious consequence: ribosomal 
renewal will be halted or insufficient. If ribosomal renewal is necessary for the sufficient 
translation of genes, then its impairment will negatively impact cellular maintenance 
(Bramham and Wells, 2007; Besse and Ephrussi, 2008). Growth will be impaired 
(Grummt, 2010), as will be the re-initiation of the cell cycle (Drygin et aI., 2010). In 
postmitotic neurons, dendritic arborization and outgrowth, as well as axon guidance and 
local protein synthesis will be negatively impacted with dysfunctional ribosome synthesis 
(Alvarez et aI., 2000; Cox et aI., 2008; Gomes et aI., 2011), resulting in the impaired 
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communication between the nucleus and distant synapses. Further, protein synthesis-
dependent forms of synaptic plasticity such as LTP would be impaired (Ostroff et ai., 
2002; Malenka, 2003). 
Yet implied in the singular impairment of ribosomal biogenesis are other 
consequences not related to protein synthesis. Impaired rDNA transcription disrupts 
nucleolar integrity allowing nucleolar proteins to diffuse into the nucleoplasm and allow 
the accumulation ofp53, which can cause apoptosis (Olson, 2004; Boulon et ai., 2010). 
Further, the reorganization of the nucleolus following mitotic nucleolar disruption is 
brought on by CDC14B, a phosphatase that reactivates SLl/TIF-lB after mitosis in 
cycling cells (Drygin et ai., 2010). Without the cooperation of a Cdk4-cyclin D/Cdk2-
cyclin EI A-mediated active UBF in early G I-phase, however, Poll-mediated 
transcription, would not be optimized. The post-mitotic reorganization process, like 
stress-induced nucleolar disruption, requires multiple steps that could be dysregulated if 
cellular stress caused the disruption (Angelier et ai., 2005; Boulon et ai., 2010; 
Hernandez-Verdun, 2011). Disassembly of the nucleolus in prophase includes the 
phosphorylation ofNPMlB23 by Cdkl-cyclin B to reduce its RNA-binding affinity. 
During anaphase RNA binding affinity is restored by the phosphatase, PPI (Negi and 
Olson, 2006; Hernandez-Verdun, 2011). Interestingly, in ATM deficient cells, PPI 
dephosphorylation ofNPMlB23 is dysregulated, thus allowing for the overexpression of 
NPMlB23, as well as its increased expression, and increased phosphorylation ofS125, 
leading to reduced p53 degradation (Tang et ai., 2008; Nalabothula et ai., 2010). This 
same phosphorylation site is an interphase casein kinase 2 (CK2) phosphorylation site 
that regulates the interaction ofNPMlB23 with other nucleolar proteins during nucleolar 
96 
re-assembly thereby contributing to the rate at which the nucleolus assembles during 
telophase (Negi and Olson, 2006). This may suggest that in ATM deficient cells where 
p53 accumulation is increased (Kamijo et aI., 1999) there is also a reduced reassembly of 
the nucleolus in telophase compared to wildtype cells, as the phosphorylation-mediated 
assembly could be mediated by changes in dissociation constants. In addition, if a 
stressful stimuli induces NPMlB23 translocation from the nucleoplasm, this may suggest 
that NPM/B23 or its upstream activator, Cdk1, is a substrate of stress-induced JNK2, 
which regulates the nucleolar stress response. The stress-induced phosphorylation by 
JNK2 on TIF-IA at T200 impairs the interaction between SLl/TIF-lB and Poll thereby 
preventing the initiation complex from forming on the rDNA promoter. Indeed, 
NPMlB23 translocation is also dependent upon JNK2 in response to UV exposure 
(Yogev et aI., 2008). These findings suggest that the phosphorylation status ofNPM/B23 
may regulate the rate at which the nucleolus can be assembled and disassembled, thus 
mutations ofNPMlB23 could have profound effects on the function and presence of the 
nucleolus. A recent discovery has identified the intergenic spacer regions of rDNA as a 
generator of stress-specific, inducible, large non-coding RNAs (IncRNA) that regulate the 
passive diffusion of specific proteins between the nucleolus and nucleoplasm. The 
IncRNAs capture proteins that display a peptidic code termed the nucleolar detection 
sequence (NoDS) and keep them in the nucleolus (Audas et aI., 2012). This new 
mechanism adds yet another layer of complexity to the nucleolar stress response and 
begins to mechanistically explain the specific diffusion of proteins under specific 
stresses. 
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In postmitotic neurons, genotoxic stress by topoisomerase I or II poisons impairs 
nucleolar transcription and causes p53-mediated apoptosis in neonates. If the exposure to 
a nucleolar-sensitive genotoxic stressor is sublethal and transient, there is evidence to 
suggest that the nucleolar response is transient also (Zhang et aI., 1988; Casafont et aI., 
2011). Indeed, within 1 day ofIR-induced DNA damage to sensory ganglion neurons, 
nucleolar transcriptional activity resumes (Casafont et aI., 2011). This suggests that the 
neuronal nucleolar transcription suppression we observed in etoposide-treated rats would 
likely have resumed had it been evaluated 1 day post treatment. Indeed, at least in rat 
neonates, we observed the resumption of an intact nucleolus as identified by the nucleolar 
presence of B23 immunostaining at 72 h post ICV etoposide delivery. Therefore, 
transient inhibition of nucleolar transcription may not induce long-term neuronal damage 
in the mature nervous system. Support for this notion comes from human neurotoxicity 
studies of chemotherapy agents, such as etoposide. For instance, the neurological side 
effects are relatively infrequent and short lasting following etoposide delivery through the 
intracarotid artery to treat brain tumors (Madajewicz et aI., 2000). The few ill effects 
noted include headache, focal seizure, blurred vision, and, most commonly, transient 
confusion. This latter effect was reported in only 8 of 168 treated individuals (Tfayli et 
aI., 1999; Madajewicz et aI., 2000). In addition, a long-term animal study evaluated 
cognitive impairment following 18-week long regiments of chemotherapy delivered by 
five systemic injections every four weeks (Lee et aI., 2006). One of the chosen drugs, 5-
FU, is known to cause nucleolar stress (Rubbi and Milner, 2003). Surprisingly, after a 7-
week recovery, LTP was enhanced, but subsequently returned to control levels at 42 
weeks. It is tempting to speculate that the initial enhancement of LTP was due to highly 
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active ribosomal biogenesis during the rebound phase following its inhibition during 
chemotherapy. This increased rate of ribosomal renewal may have replaced numerous 
damaged ribosomes with impaired function. With increased numbers of functioning 
ribosomes, local protein synthesis may have been enhanced and successful 
communication between the nucleus and synapses enhanced. Further, increased 
accumulation ofp53 in the nucleus following nucleolar disruption is likely to have 
ceased, and along with it the ceasing of enhanced stress-mediated responses. Therefore, 
if in the mature nervous system the impairment of Poll-mediated transcription is 
transient, it may produce no residual neuronal deficits (Fig. 17). To be certain, more 
work is required to quantify the cellular recovery rate by genotoxin type, delivery and 
dose, as well as by recovery period and age at treatment. Indeed, reports of chemobrain, 
also termed chemotherapy-induced cognitive impairment, are most commonly associated 
with treatments of breast cancer, but remain elusive as to the triggers, treatment 
conditions that potentiate it, and duration (Kannarkat et aI., 2007; Whitney et aI., 2008; 
Argyriou et aI., 2010; Mitchell and Turton, 2011). Though the frequency of associations 
are ever increasing, little is understood about the susceptibility of patients to chemobrain. 
This is partially due to the primarily descriptive and associative nature of chemobrain 
reports, but also confounded by the variation in ages of chemotherapy onset and post 
treatment longevity (Argyriou et aI., 2010). 
The effects of genotoxic stress on postmitotic neurons could be compounded by 
age as they are postmitotic and dependent on translation for cellular maintenance and 
synaptic plasticity. Therefore, it may be anticipated that progressive, impaired ribosomal 
biogenesis could result in dysfunction or neurodegeneration. Indeed, the repetitive nature 
99 
of the rDNA tandem repeats increases the susceptibility of rDNA to recombination, and 
has been associated with regulating senescence in yeast (Kobayashi, 2011). Moreover, 
mammalian age-related rDNA gene loss were described in the early 1970s (Johnson and 
Strehler, 1972), suggesting that impaired ribosomal biogenesis is a consequence of 
natural aging. Further, age-related loss of rDNA has been observed in the human cerebral 
cortex (Strehler et aI., 1979), and 5S and 28S rRNA genes have been shown to be 
preferentially lost in human adipose tissue during natural aging (Zafiropoulos et aI., 
2005). Interestingly, rDNA loci were increased in the parietal and prefrontal cortex of 
postmortem Alzheimer's Disease patients, compared to age-matched controls, as was 
cytosine methylation at the rDNA promoter (Pietrzak et aI., 20lla). This could be 
explained by increased stability of silenced, hypermethylated rDNA. Indeed, increased 
cytosine methylation has been shown to stabilize yeast rRNA genes (Kennedy et aI., 
1997). Further, prematurely senescent primary fibroblasts from human Werner syndrome 
(WS), a progeroid disorder, did not display any locus instability, but showed increased 
cytosine methylation within rRNA genes (Machwe et aI., 2000). 
The DNA damage repair pathway, nucleotide excision repair (NER), has recently 
been associated with rDNA transcription (Assfalg et aI., 2011). Mutations ofTFIIH 
subunits associated with Cockayne syndrome impair rDNA transcription. The authors 
indicate that TFIIH, a general transcription factor of RNA Polymerase II, is essential for 
rDNA promoter occupancy and Poll-mediated transcriptional elongation. Indeed, these 
findings suggest that the progeroid disorder, Cockayne syndrome, and perhaps other 
mutations ofNER that cause progeria and cancer predisposition have associations with 
impaired ribosomal biogenesis. 
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Recent years have brought growing evidence for an association between reduced 
ribosomal biogenesis and neurodegenerative diseases. Tamoxifen-induced ablation of 
Tif-la in the mature CNS potentiates noticeable cell loss in the dentate gyrus and CA 
regions of the hippocampus beginning at one month post tamoxifen treatment (Parlato et 
aI., 2008). The ablation ofTif-la in mature mouse dopaminergic neurons leads to 
reduced cell number and a Parkinsonian phenotype that can be rescued by L-Dopa 
administration (Rieker et aI., 2011). Indeed, translocation ofNPMlB23 from the 
nucleolus to the nucleoplasm and decreased visibility of nucleoli has been observed in 
dopaminergic neurons of postmortem Parkison's patients (Rieker et aI., 2011). In the 
CAG expanded repeat disorder, Huntington's Disease (HD), dysfunctional UBF 
acetylation impairs UBF occupancy on the rDNA promoter in a mouse model ofHD. In 
addition, these authors observed reduced UBF protein levels in human postmortem 
striatum (Lee et aI., 2011). In Alzheimer's Disease (AD), the presence of decreased 
polyribosomal function has been described in the postmortem parietal cortex (Ding et aI., 
2005). The ribosomal dysfunction is at least partially associated with increased rRNA 
oxidation (Ding et aI., 2006). Further, increased rRNA oxidation by iron binding has 
been identified in the AD postmortem hippocampal cytoplasm. Moreover, AD associated 
oxidative damage resulted in 8-hydroxyguanosine insults, which were not witnessed in 
age-matched controls (Honda et aI., 2005). There has also been neuronal nucleolar 
atrophy, a symptom of reduced Poll-mediated transcriptional activity, identified in AD 
postmortem hippocampi and cerebral cortices (Tagliavini and Pilleri, 1983; Mann et aI., 
1988; Iacono et aI., 2008). In addition, Prader-Willi Syndrome (PWS) patients and 
mouse models ofPWS have recently been shown to have atrophic Purkinje cell nucleoli 
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(Leung et al., 2009). Interestingly, published electron micrographs may suggest the 
absence of nucleoli in Purkinje cells of Atm-/- mice, indicating that the cerebellar 
neurodegeneration associated with ATM deficiency may be associated with nucleolar 
disruption (Kuljis et al., 1997). Further, deficiency of ATM results in increased 
accumulation of iron and subsequent increased accumulation of oxidative stress 
(McDonald et al., 2011). Thus, the absence of ATM may potentiate the rRNA-targeted 
oxidative stress and ribosomal dysfunction. These findings are particularly interesting in 
light of results presented herein pertaining to the regulation of Poll transcription by 
ATM, as it suggests that long-term (i.e., life-time of the animal) insufficient ribosomal 
biogenesis may cause a permanent collapse of nucleoli leading to cellular degeneration. 
Therefore, the renewal of neuronal ribosomes may be necessary to prevent consequences 
of oxidative stress including ribosomal failure. Conversely, chronic nucleolar 
transcriptional impairment may tum rRNA to be an oxidative stress sink. This notion 
favors a long accumulation of oxidative insult with pathology evidenced after years, 
consistent with many neurodegenerative diseases, including A-T. Importantly, these 
nucleolar associations with neurodegenerative disease do not claim to be causative. 
Though deletion of Poll transcription (Rieker et al., 2011) is able to cause the symptoms 
associated with PD as a proof of principle, the ablation of nucleolar transcription is 
unlikely. Therefore, additional work is required to identify biological consequences of 
nucleolar insufficiency in neurodegenerative conditions such as A-T. 
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The nucleolus as a therapeutic target 
The breadth of functions associated with the nucleolus make it an enticing candidate for 
targeted therapies. NPM/B23 is an exciting potential therapeutic target because it has the 
capability of promoting nucleolar disruption, which could be useful in cancer therapy, 
while it also has the potential to promote nucleolar assembly and euchromatin formation. 
The phosphorylation ofNPMIB23 can cause disruption of the nucleolus, which, if 
targeted and constitutive, would cease tumor growth. Conversely, constitutive 
phosphorylation at S 125 may promote rapid reassembly of a disrupted nucle9lus that 
could prevent transient or permanent cellular damage. Similarly, as the phosphorylation 
of these residues are mediated by Cdks and CK2, respectively, these kinases may offer 
further target potential to manipulate the structural status of the nucleolus through 
NPMlB23. NPMlB23 has already been shown to be a downstream target of ATM 
(Nalabothula et al., 2010), presumably under conditions of cellular stress, but it may also 
be a target that mediates Poll-mediated transcriptional regulation by ATM. 
Constitutively activating NPM/B23 at S125 may rescue insufficient nucleolar 
transcription in ATM deficient cells. Indeed the number of protein-protein interactions 
with ATM in the nucleolus is regularly increasing. SIRT7 is one such newly discovered 
ATM-interacting protein (Tsai et al., 2011) that has been shown to be essential for 
nucleolar transcription (Ford et al., 2006; Grob et al., 2009). Thus, SIRT7 may be another 
target of ATM to promote nucleolar transcription. Though SIRT7 has been shown to 
have very limited deacetylase activity (Tsai et al., 2011), it is required for Poll 
transcription (Grob et al., 2009). Given the attention paid to sirtuins in the pharmaceutical 
industry, this target may be a low-hanging fruit. 
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Components of the Poll initiation complex are convenient targets for potential 
therapies as well, with potentially numerous substrates that affect transcriptional 
initiation and elongation. Indeed, constitutively active TIF-IA has been effective way to 
selectively stimulate Poll under numerous conditions (Grummt, 2010; Gomes et aI., 
2011). Many groups have already attempted to target the phosphatase CDCI4B for its 
dephosphorylation ofSLl/TIF-IB to reset the Poll initiation complex after mitosis 
(Mocciaro and Schiebel, 20 I 0). This phosphatase remains an interesting target, as does 
SLl/TIF -I B in the field of cancer, as tumorigenesis would presumably not resume if 
CDCI4B were unable to reactivate SLl/TIF-IB. However, overexpression ofCDCI4B 
is now thought to be oncogenic, suggesting multiple functionality of this phosphatase 
(Wei and Zhang, 2011). UBF has been identified in HD patients as being poorly 
expressed, thus therapies that may increase its expression and interactions with the rDNA 
promoter and Poll initiation complex may prove beneficial. 
Given the recent associations between nucleolar dysfunction and disease there is 
hope that therapeutic interventions targeting the nucleolus will emerge. Indeed the 
plurifunctionality of the nucleolus is becoming more and more evident. Therefore, I 
speculate that the list of genes that regulate nucleolar function and are associated with 
diseases will only become longer, thus prompting more development efforts towards 
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Figure 17. Chronic nucleolar transcriptional impairment leads to 
neurodegeneration 
Sustained Poll-mediated transcriptional inhibition by either persistent genotoxic insult or 
A TM deficiency leads to decreased sufficiency of protein synthesis. The persistence of 
these events may lead to neurodegeneration. 
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